Über die Bedeutung von Streptokokkeninfektionen in der Pathogenese der akuten Polyarthritis und der akuten Neprithis

  • P. Christ
Part of the Ergebnisse der Inneren Medizin und Kinderheilkunde book series (KINDERHEILK. NF, volume 11)

Zusammenfassung

In der vorliegenden Arbeit sollen die Erkenntnisse über die Bedeutung von Streptokokkeninfektionen in der Pathogenese der akuten Polyarthritis und der akuten Nephritis dargestellt werden. Die Arbeit befaßt sich vorwiegend mit klinischen und serologischen Fragen. Die Darstellung berücksichtigt die in der Literatur mitgeteilten Befunde und eigene Untersuchungsergebnisse des Verfas­sers, besonders über Antikörper gegen hämolytische Streptokokken und gelbe hämolytische Staphylokokken.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Addis, T.: Glomerular Nephritis. Diagnosis and Treatment. New York: Macmillan 1948. Albertini, A. von, u. A. Grumbach: Ergebnisse experimenteller Forschung zur Frage derGoogle Scholar
  2. Herdinfektion. Schweiz, med. Wschr. 1938, 1309–1315.Google Scholar
  3. Albrecht, U.: Perorale Penicillin-Behandlung des Scharlachs. Dtsch. med. Wschr. 1955, 76–78.Google Scholar
  4. Aldrich, C. A.: Nephritis. In Brennemann’s Practice of Pediatrics III/Kap. 28, 1–41. Hagerstown, Maryland: W. F. Prior Company 1943.Google Scholar
  5. Allan, W. B., and J. W. Baylor: The influence of tonsillectomy upon the course of rheumatic fever and rheumatic heart disease. Bull. Johns Hopk. Hosp. 63, 111–123 (1938).Google Scholar
  6. Anderson, H. C., H. G. Kunkel and M. McCarty: Quantitative antistreptokinase studies in patients infected with group A hemolytic streptococci: A comparison with serum antistreptolysin and gamma globulin levels with special reference to the occurrence of rheumatic fever. J. clin. Invest. 27, 425-434 (1948).Google Scholar
  7. Andrewes, C. H., C. L. Derick and H. F. Swift: The skin response of rabbits to non-hemo- lytic streptococci. I. Description of a secondary reaction occurring locally after intradermal inoculation. J. exp. Med. 44, 35–53 (1926).Google Scholar
  8. Angevine, D. M.: A comparison of cutaneous sensitization and antibody formation in rabbits immunized by intravenous or intradermal injections of indifferent or hemolytic streptococci and pneumococci. J. exp. Med. 73, 57–66 (1941).PubMedGoogle Scholar
  9. Angevine, D. M., S. Rothbard and R. L. Cecil: Cultural studies on rheumatoid arthritis and rheumatic fever. J. Amer. med. Ass. 115, 2112–2114 (1940).Google Scholar
  10. Aronson, J. D.: Incidence of tuberculous infection in some communities of the South. Amer. J. Hyg. 14, 374–393 (1931).Google Scholar
  11. Aronson, J. D.: The fluctuation of the tuberculin reaction in different geographic areas and its relationship to resistance. Amer. Rev. Tuberc. 63, 121–139 (1951).Google Scholar
  12. Arthus, M.: Injections répétées de sérum de cheval chez le lapin. C. R. Soc. Biol. (Paris) 55, 817–820 (1903).Google Scholar
  13. Arthus, M., M. Breton: Lésions cutanées produites par les injections de sérum de cheval chez le lapin anaphylactisé par et pour ce sérum. C. R. Soc. Biol. (Paris) 55, 1478–1480 (1903).Google Scholar
  14. Aschoff, L: Zur Myocarditisfrage. Verh. dtsch. Ges. Path. 8. Tagg. 46–53 (1904).Google Scholar
  15. Aschoff, L: Das rheumatische Leiden im Lichte der deutschen Pathologie. Dtsch. med. Wschr. 1934, 7–11.Google Scholar
  16. Aschoff, L: Über den Begriff der allergischen Krankheiten. Med. Klin. 1935, 1–3.Google Scholar
  17. Ash, R: Influence of tonsillectomy on rheumatic infection. Amer. J. Dis. Child. 55, 63–78 (1938).Google Scholar
  18. Ash, R: Rheumatic infection in childhood: Fifteen to twenty-year follow-up. Amer. J. Dis. Child. 76, 46–52 (1948).Google Scholar
  19. Badger, G. F., J. H. Dingle, A. E. Feller, R. G. Hodges, W. S. Jordan and Ch. H. Rammelkamp: A study of illness in a group of Cleveland families. Amer. J. Hyg. 58, 31–46 (1953).PubMedGoogle Scholar
  20. Baehr, G., and H. Lande: Glomerulonephritis as a complication of subacute streptococcus endocarditis. J. Amer. med. Ass. 75, 789–790 (1920).Google Scholar
  21. Baker, B. M., C.B. Thomas and R. M. Penick: Experimental carditis. Changes in the myocardium and pericardium of rabbits sensitized to streptococci. J. clin. Invest. 14, 465–473 (1935).PubMedGoogle Scholar
  22. Bates, R. C., R. B. Jennings and D. P. Earle: Acute nephritis unrelated to group A hemolytic streptococcus infection. Amer. J. Med. 23, 510–528 (1957).PubMedGoogle Scholar
  23. Bell, E. T: Glomerular lesions associated with endocarditis. Amer. J. Path. 8, 639–664 (1932).PubMedGoogle Scholar
  24. Benacerraf, B., and E. A. Kabat: Quantitative study of the Arthus phenomenon induced passively in the guinea pig. J. Immunol. 64, 1–19 (1950).PubMedGoogle Scholar
  25. Bennike, T., K. Brochner-Mortensen, E. Kjaer, K. Skadhauge and E. Trolle: Penicillin therapy in acute tonsillitis, phlegmonous tonsillitis and ulcerative tonsillitis. Acta med. scand. 139, 253–274 (1951).PubMedGoogle Scholar
  26. Berger, U: Weitere Untersuchungen über Vorkommen und Eigenschaften hämolysierender Streptokokken bei den entzündlichen Paradentopathien. Z. Hyg. 139, 372–384 (1954).Google Scholar
  27. Bergqvist, S: Staphylococci and antihyaluronidase; sero-bacteriologic and clinical investigation with special reference to tuberculosis. Acta med. scand. (Suppl. 267) 143, 1–80 (1952).Google Scholar
  28. Bernheimer, A. W: Streptolysins and their inhibitors. In Streptococcal infections. Edited by M. McCarty. S. 19–38. New York: Columbia Univ. Press. 1954.Google Scholar
  29. Bernheimer, A. W., P. D. Lazarides and A. T. Wilson: Diphosphopyridine nucleotidase as an extracellular product of streptococcal growth and its possible relationship to leukotoxicity. J. exp. Med. 106, 27–37 (1957).PubMedGoogle Scholar
  30. Bernheimer, A. W., M. Rodbart: The effect of nucleic acids and of carbohydrates on the formation of streptolysin. J. exp. Med. 88, 149–168 (1948).PubMedGoogle Scholar
  31. Bieling, R: Herdinfektion und Immunität. Verh. dtsch. Ges. inn. Med. 42, 438–451 (1930).Google Scholar
  32. Bigger, J. W., and G. A. Hodgson: Impetigo contagiosa; its cause and treatment. Lancet 1943 I, 544–547.Google Scholar
  33. Bingold, K: Erysipel. In Handbuch der Inneren Medizin, herausgeg. von G. von Bergmann, W. Frey, H. Schwiegk, 4. Aufl., 1/1, S. 1172–1201. Berlin: Springer 1952.Google Scholar
  34. Biörck, G: Rheumatic heart disease as a problem of preventive cardiology. J. chron. Dis. 1, 591–600 (1955).PubMedGoogle Scholar
  35. Bland, E. F., and T. D. Jones: Clinical observations on events preceding appearance of rheumatic fever. J. clin. Invest. 14, 633–648 (1935).PubMedGoogle Scholar
  36. Rheumatic fever and rheumatic heart disease: A twenty-year report on 1000 patients followed since childhood. Circulation 4, 836–843 (1951).Google Scholar
  37. Blatt, H., F. A. Nantz and J. M. Rehm: An improved tissue culture technique adaptable to clinical testing for bacterial hypersensitivity of the tuberculin type. Ann. Allergy 7, 170–171 (1949).PubMedGoogle Scholar
  38. Boake, W. C., and H. Muir: The non-antigenicity of chondroitin sulphate. Lancet 1955II, 1222–1223.Google Scholar
  39. Böhmig, R: Über homologe und heterologe Testinfektionen mit Streptokokken in verschiedenen Stadien der Immunität. Z. Hyg. 115, 406–430 (1933).Google Scholar
  40. Böhmig, R., P. Klein: Pathologie und Bakteriologie der Endocarditis. Berlin: Springer 1953.Google Scholar
  41. Böhmig, R., H. F. Swift: Comparative histologic reactions in cutaneous lesions induced by streptococci in rabbits previously inoculated intracutaneously or intravenously. Arch. Path. (Chicago) 15, 611–630 (1933).Google Scholar
  42. Bottyan, I: Herdinfektion–stomatogene Allergisierung. Z. Stomat. 36, 189–194 (1938) .Google Scholar
  43. Bouillaud, J. B: Traité clinique du Rheumatisme. 1840; zit. nach Schoen und Tischendorf.Google Scholar
  44. Boyksen, O: Beobachtungen über die Scharlachepidemie in Pinneberg 1937. Z. Hyg. 120, 466–477 und 478–481 (1938).Google Scholar
  45. Brand, Gr., F. A. Weihe: Polyarthritis rheumatica bei Zwillingen. Z. menschl. Vererb.- u. Konstit.-Lehre 23, 169–188 (1939).Google Scholar
  46. Brand, Gr: Der Erbeinfluß bei Polyarthritis rheumatica. Z. menschl. Vererb.- u. Konstit.-Lehre 27, 199–223 (1943).Google Scholar
  47. Breese, B. B., and F. A. Disney: The accuracy of diagnosis of beta streptococcal infections on clinical grounds. J. Pediat. 44, 670–673 (1954).PubMedGoogle Scholar
  48. Bright, R: Cases and observations, illustrative of renal disease accompanied with the secretion of albuminous urine. G-uys Hosp. Rep. 1, 338–400 (1836).Google Scholar
  49. Broccoliche-Foulet, J: A propos du caractère familial de la maladie de Bouillaud. Diss. Paris 1954.Google Scholar
  50. Brock, L. L., and A. C. Siegel: Studies on the prevention of rheumatic fever: The effect of time of initiation of treatment of streptococcal infections on the immune response of the host. J. clin. Invest. 32, 630–632 (1953).PubMedGoogle Scholar
  51. Brown, J. H., and J. G. Schaub: Relation of streptococci to human disease; importance of identification and nomenclature; streptococci other than those of group A. Aer. J. med. Sci. 209, 388–394 (1945).Google Scholar
  52. Brtjun, E: Allergische Arthritis und Myokarditis. Virchows Arch. path. Anat. 303, 524–551 (1939) .Google Scholar
  53. Burkhardt, F., u. F. Legler: Über die Mehrausbeute an beta-hämolytischen Streptokokken bei anaerober Züchtung. Arch. Hyg. 140, 418–422 (1956).Google Scholar
  54. Butler, W: The intermittent infectiousness of scarlet fever. Proc. roy. Soc. Med., London 2, Sect. Epidem., 59–88 (1908/09).Google Scholar
  55. Bywaters, E. G. L., I. Isdale and J. J. Kempton: Schönlein-Henoch purpura. Evidence for a group A hemolytic streptococcal aetiology. Quart. J. Med. 26, 161–175 (1957).PubMedGoogle Scholar
  56. Carlson, A. S., A. Kellner and A. W. Bernheimer: Selective inhibition by preparations of streptococcal filtrates of the oxidative metabolism of mitochondria procured from rabbit myocardium. J. exp. Med. 104, 577–587 (1956).PubMedGoogle Scholar
  57. Carlson, A. S., E. B. Freeman: A streptococcal enzyme that acts specifically upon diphos- phopyridine nucleotide: Characterization of the enzyme and its separation from streptolysin O. J. exp. Med. 100, 15–26 (1957).Google Scholar
  58. Catanzaro, F. J., Ch. H. Rammelkamp and R. Chamovitz: Prevention of rheumatic fever by treatment of streptococcal infections. II. Factors responsible for failures. New Engl. J. Med. 259, 51–57 (1958).Google Scholar
  59. Catanzaro, F. J., F. J., Ch. A. Stetson, A. J. Morris, R. Chamovitz, Ch. H. Rammelkamp, B. L. Stolzer and W. D. Perry: The role of the streptococcus in the pathogenesis of rheumatic fever. Amer. J. Med. 17, 749–756 (1954).Google Scholar
  60. Cecil, R. L., E. E. Nicholls and W. J. Stainsby: Bacteriology of the blood and joints in rheumatic fever. J. exp. Med. 50, 617–642 (1929).PubMedGoogle Scholar
  61. Chase, M. W: (1) The allergic state. In Bacterial and mycotic infections of man, 2nd ed. Edited by R. J. Dubos. Philadelphia: J. B. Lippineott 1952.Google Scholar
  62. Chase, M. W: (2) The role of formed elements of blood in allergy and hypersensitivity. J. Allergy 26, 242–248(1955).Google Scholar
  63. Chase, M. W: (3) The mechanism of sensitization. J. Allergy 28, 30–38 (1957).PubMedGoogle Scholar
  64. Cheadle, W. B: The nation’s manifestation of the rheumatic state as exemplified in childhood and early life. Lectures delivered before the Harveian Society of London. London: Smith Elder and Co. 1889.Google Scholar
  65. Choucroun, N: Tubercle bacillus antigens. Amer. Rev. Tuberc. 56, 203–226 (1947).Google Scholar
  66. Christ, P: (1) Untersuchungen mit der Antistreptokinase-, der Antihyaluronidase- und der Antistreptolysin-Reaktion. Z. Rheumaforsch. 12, 141–156 (1953).PubMedGoogle Scholar
  67. Christ, P: (2) Serologische Untersuchungen bei Streptokokkeninfektionen. Arb. Paul-Ehrlich-Inst. Frankfurt a. M. H. 51, 124–166 (1954).Google Scholar
  68. Christ, P: (3) Über Erkrankungen durch anaerobe, nicht sporenbildende Bakterien. Dtsch. Arch, klin. Med. 203, 186–200 (1956).Google Scholar
  69. Christ, P: (4) Klinische und bakteriologische Beobachtungen bei septischen Erkrankungen. Klin. Wschr. 1957, 1098.Google Scholar
  70. Christ, P., E. Vanek, K. H. Krachudel u. H.-J. Becker: In Vorbereitung.Google Scholar
  71. Christensen, L. R: Streptococcal fibrinolysis: a proteolytic reaction due to a serum enzyme activated by streptococcal fibrinolysin. J. gen. Physiol. 28, 363–383 (1945).PubMedGoogle Scholar
  72. Christ, P: The activation of plasminogen by chloroform. J. gen. Physiol. 30, 149–157 (1946).Google Scholar
  73. Christ, P: Methods for measuring the activity of components of the streptococcal fibrinolytic system, and streptococcal desoxyribonuclease. J. clin. Invest. 28, 163–172 (1949).Google Scholar
  74. Christ, P: The streptokinase-plasminogen system. In Streptococcal infections. Edited by M. McCarty. S. 39–55. New York: Columbia University Press 1954.Google Scholar
  75. Christ, P., C. M. MacLeod: A proteolytic enzyme of serum: characterization, activation and reaction with inhibitors. J. gen. Physiol. 28, 559–583 (1945).Google Scholar
  76. Clausen, F: Beiträge der Zwillingsforschung zum Rheuma-Problem. Z. Rheumaforsch. 14, 145–152 (1955).Google Scholar
  77. Christ, P., F. Steiner: Die Bedeutung der Konstitution für die Erkrankung an Gelenkrheumatismus. Verh. dtsch. Ges. inn. Med. 1938, 299–303.Google Scholar
  78. Coburn, A. F: The factor of infection in the rheumatic state. Baltimore: Williams and Wilkins, 1931.Google Scholar
  79. Christ, P: Rheumatic fever problem. I. Present status. Amer. J. Dis. Child. 70, 339–347 (1945).Google Scholar
  80. Christ, P: Some basic, unsolved problems in the prevention of rheumatic fever. Ann. intern. Med. 47, 402–417 (1957).Google Scholar
  81. Christ, P., R. H. Paijli: Studies on the relationship of streptococcus hemolyticus to the rheumatic process. I. Observations on the ecology of hemolytic streptococcus in relation to the epidemiology of rheumatic fever. J. exp. Med. 56, 609–632 (1932). III. Observations on the immunological response of rheumatic subjects to hemolytic streptococcus. J. exp. Med. 56, 651–676 (1932).Google Scholar
  82. Christ, P: Limited observations on the antistreptolysin titer in relation to latitude. J. Immunol. 29, 515–521 (1935).Google Scholar
  83. Christ, P: Studies on the immune response of the rheumatic subject and its relationship to activity of the rheumatic process; observations on an epidemic of influenza followed by hemolytic streptococcus infections in a rheumatic colony. J. exp. Med. 62, 137–158 (1935).Google Scholar
  84. Christ, P: Studies on the immune response of the rheumatic subject and its relationship to activity of the rheumatic process; characteristics of strains of hemolytic streptococcus, effective and noneffective in initiating rheumatic activity. J. clin. Invest. 14, 755–762 (1935).Google Scholar
  85. Christ, P: Splenectomie in relation to the development of rheumatic activity. J. clin. Invest. 14, 783–791 (1935).Google Scholar
  86. Christ, P., D. C. Young: The epidemiology of hemolytic streptococcus during world war II in the United States Navy. Baltimore: Williams and Wilkins 1949.Google Scholar
  87. Coca, A. F: Zur Frage der Identität der anaphylaktischen und der atopischen Überempfindlichkeit. Med. Klin. 1925, 57–60.Google Scholar
  88. Christ, P., E. F. Grove: Studies in hypersensitiveness. XIII. A study of the atopic reagins. J. Immunol. 10, 445–464 (1925).Google Scholar
  89. Collins, S.D: The incidence of rheumatic fever as recorded in general morbidity survey of families. Publ. Health Rep. (Wash.) Suppl. 198 (1947); zit. nach Rammelkamp (4).Google Scholar
  90. Collis, W. R. F: Acute rheumatism and hemolytic streptococci. Lancet 19311, 1341–1345.Google Scholar
  91. Christ, P: Bacteriology of rheumatic fever. Lancet 1939 II, 817–820.Google Scholar
  92. Christ, P., W. Sheldon, and N. G. Hill: Cutaneous reactions in acute rheumatism. Quart. J. Med. 1, 511–525 (1932).Google Scholar
  93. Christ, P: Commission on Acute Respiratory Diseases: Endemic exsudative pharyngitis and tonsillitis. Etiology and clinical characteristics. J. Amer. med. Ass. 125, 1163–1169 (1944).Google Scholar
  94. Christ, P: Commission on Acute Respiratory Diseases: Role of hemolytic streptococci in common respiratory disease. Amer. J. publ. Hlth 35, 675–682 (1945).Google Scholar
  95. Commission on Acute Respiratory Diseases: Studies on streptococcal fibrinolysis. IV: Clinical application of a quantitative antifibrinolysin test. J. clin. Invest. 25, 352–359 (1946). V: The in vitro production of fibrinolysin by various groups and types of beta hemolytic streptococci; relationship to antifibrinolysin production. J. exp. Med. 85, 441–457 (1947).Google Scholar
  96. Commission on Acute Respiratory Diseases: The role of Lancefield groups of beta-hemolytic streptococci in respiratory infections. New Engl. J. Med. 236, 157–166 (1947).Google Scholar
  97. Commission on Acute Respiratory Diseases: Exsudative tonsillitis and pharyngitis of unknown cause. J. Amer. med. Ass. 133, 588–593 (1947).Google Scholar
  98. Commissions on Acute Respiratory Diseases: Problems in determining the bacterial flora of the pharynx. Proc. Soc. exp. Biol. (N. Y.) 69, 45–52 (1948).Google Scholar
  99. Committee on Prevention of Rheumatic Fever and Bacterial Endocarditis: Prevention of rheumatic fever and bacterial endocarditis through control of streptococcal infections. Circulation 15, 154–158 (1957).Google Scholar
  100. Conta, G. von: Untersuchungen über Polyarthritis acuta rheumatica und Herdinfektion. Klin. Wschr. 1930, 2140–2144.Google Scholar
  101. Coons, A. H: The penetration of antigens into connective tissue. In Rheumatic fever. Edited by L. Thomas. S. 217–223. Minneapolis: University of Minnesota Press 1952.Google Scholar
  102. Copeman, W. S. C: Observations on natural history of acute rheumatic fever. Ann. rheu- mat. Dis. 4, 11–21 (1944).Google Scholar
  103. Coulter, J. E: Rheumatic fever and streptococcal illness in two communities in New York State, Milbank Mem. Fund Quart. 30, 341–348 (1952).Google Scholar
  104. Crowley, N: Hyaluronidase production by hemolytic streptococci of human origin. J. Path. Bact. 56, 27–35 (1944).Google Scholar
  105. Cruickshank, C. N. D: Sensitivity to tuberculin. Nature (Lond.) 168, 206–207 (1951).Google Scholar
  106. Cruickshank, R: The epidemiology of some skin infections. Brit. med. J. 1953 I, 55–59.Google Scholar
  107. Daikos, G., and L. Weinstein: Streptococcal bacteriostatic antibody in patients treated with penicillin. Proc. Soc. exp. Biol. (N. Y.) 78, 160–163 (1951).Google Scholar
  108. Dawson, M. H., M. Olmstead and R. H. Boots: Studies on the etiology of rheumatoid arthritis. I. Bacteriological investigations on blood, synovial fluid and subcutaneous nodules in rheumatoid arthritis. Proc. Soc. exp. Biol. (N. Y.) 28, 419–420 (1931).Google Scholar
  109. Denny, F. W: The prophylaxis of streptococcal infections. In Streptococcal infections. Edited by M. McCarty. S. 176–196. New York: Columbia University Press 1954.Google Scholar
  110. Denny, F. W., W.D.Perry, and L. W. Wannamaker: Tvpe-specific streptococcal antibody. J. clin. Invest. 36, 1092–1100 (1957).Google Scholar
  111. Denny, F. W., L. Thomas: The demonstration of type specific streptococcal antibody by a hemagglutinin technique employing tannic acid. J. clin. Invest. 32, 1085–1093 (1953).PubMedGoogle Scholar
  112. Denny, F. W: Persistence of group A streptococci in tissues of rabbits after infection. Proc. Soc. exp. Biol. (N. Y.) 88, 260–263 (1955).Google Scholar
  113. Denny, F. W., L. W. Wannamaker, W. R. Brink, Ch. H. Rammelkamp and E. A. Custer: Prevention of rheumatic fever. Treatment of the preceding streptococcic infection. J. Amer. med. Ass. 143, 151–153 (1950).Google Scholar
  114. Denny, F. W., Ch. H. Rammelkamp: The relation of antibody production to the development of rheumatic fever. Amer. J. Dis. Child. 80, 506–507 (1950).Google Scholar
  115. Derick, C. L., C. H. Hitchcock, and H. F. Swift: Reactions of rabbits to non-hemolytic streptococci. Ill: A study of modes of sensitization. J. exp. Med. 52, 1–22 (1930).PubMedGoogle Scholar
  116. Derick, C. L., H. F. Swift: Reactions of rabbits to non-hemolytic streptococci. I: General tuberculin-like hypersensitiveness, allergy or hyperergy following the secondary reaction. J. exp. Med. 49, 615–636 (1929).PubMedGoogle Scholar
  117. Deutsche Arbeitsgemeinschaft für Herdforschung und Herdbekämpfung: Kritische Betrachtung des Herdgeschehens. München: Carl Hanser 1955.Google Scholar
  118. Dick, G. F., and G. H.Dick: Experimental scarlet fever. J. Amer. med. Ass. 81, 1166–1167 (1923).Google Scholar
  119. Dienes, L: The technique of producing tuberculin type of sensitization with eggwhite in tuberculous guinea pigs. J. Immunol. 17, 531–538 (1929).Google Scholar
  120. Dienes, L., T. B. Mallory: Histological studies of hypersensitive reaction. Amer. J. Path. 8, 689–700 (1932).PubMedGoogle Scholar
  121. Dietrich, A: Versuche über Herzklappenentzündung. Z. ges. exp. Med. 50, 85–92 (1926).Google Scholar
  122. Dingle, J. H: (1) Common virus infections of respiratory tract; diagnosis and etiology. J. Amer. med. Ass. 136, 1084–1088 (1948).Google Scholar
  123. Dienes, L: (2) The clinical pattern of streptococcal infection in man. In Streptococcal infections. Edited by M. McCarty. S. 120–129. New York: Columbia University Press 1954.Google Scholar
  124. Dienes, L., G. F. Badger, A. E. Feller, R. G. Hodges, W. S. Jordan and Ch. H. Rammelkamp: A study of illness in a group of Cleveland families. Amer. J. Hyg. 58, 16–46 (1953).Google Scholar
  125. Dienes, L., Ch. H. Rammelkamp, and L. W. Wannamaker: Epidemiology of streptococcal infections and their non-suppurative complications. Lancet 1953 I, 736–738.Google Scholar
  126. Dixon, F. J., J. J. Vazquez, W. O. Wigle and C. G. Cochrane: Pathogenesis of serum sickness. Arch. Path. (Chicago) 65, 18–28 (1958).Google Scholar
  127. Dohmen, A: Scarlatiniforme Exantheme bei Infektionen mit dem Staphylococcus aureus haemolyticus. Klin. Wschr. 1938, 1689–1691.Google Scholar
  128. Draper, G: Studies in human constitution. No. IV. Heredity and environment–the disease makers. Amer. J. Med. Sci. 171, 803–813 (1926).Google Scholar
  129. Dresner, E: Aetiology and pathogenesis of rheumatoid arthritis. Amer. J. Med. 18, 74–111 (1955).PubMedGoogle Scholar
  130. Dresner, E: Some current concepts of the etiology of rheumatoid arthritis. J. Chron. Dis. 5, 612–629 (1957).PubMedGoogle Scholar
  131. Earle, D. P., and D. Seegal: Natural history of glomerulonephritis. J. Chron. Dis. 5, 3–13 (1957).PubMedGoogle Scholar
  132. Edström, G: Mechanisches Trauma und nachfolgende Febris rheumatica. Acta med. scand. 88, 342–354 (1936).Google Scholar
  133. Edström, G: Die Klinik des rheumatischen Fiebers. Ergebn. inn. Med. Kinderheilk. 52, 439–503 (1937).Google Scholar
  134. Edström, G: Klinische Studien über den chronischen Gelenkrheumatismus. I. Das Erbbild. Acta med. scand. 108, 398–413 (1941).Google Scholar
  135. Edström, G: Klinische Studien über den chronischen Gelenkrheumatismus. IV. Trauma und Rheumatismus. Acta med. scand. 111, 150–171 (1942).Google Scholar
  136. Edström, G: Rheumatoid arthritis and trauma. Acta med. scand. 142, 11–30 (1952).PubMedGoogle Scholar
  137. Edström, G: Rheumatic fever, its symptoms, prevention and treatment. Acta rheum, scand. 1, 145–173 (1955).Google Scholar
  138. Eigler, G., F. Heiss u. W. Schwenckendiek: Über den Antistaphylolysintiter bei entzündlichen Tonsillenerkrankungen. Z. Laryng. Rhinol. 36, 22–30 (1957).Google Scholar
  139. Elliot, S.D: The crystallization and serological differentiation of a streptococcal proteinase and its percusor. J. exp. Med. 92, 202–218 (1950).Google Scholar
  140. Empire Rheumatism Council: A controlled investigation into the aetiology and clinical features of rheumatoid arthritis. Brit. med. J. 19501, 799–805.Google Scholar
  141. Ernst: Zit. nach F. Volhard.Google Scholar
  142. Escherich, Th., und B. Schick: Der Scharlach. Wien: Holder 1912.Google Scholar
  143. Faber, V: Anti-streptococcal-hyaluronidase. I. The turbidimetric method for determination of anti-streptococcal-hyaluronidase (ASH) in serum. Acta path, microbiol. scand. 32, 147–156 (1953).Google Scholar
  144. Favour, C. B: [1] Cell injury in allergic inflammation. Internat. Arch. Allergy 10, 193–224 (1957).Google Scholar
  145. Favour, C. B: [2] Persönliche Mitteilung.Google Scholar
  146. Favour, C. B., B. A. Harrison, and Ch. K. Osgood: Increased in vitro tuberculin leucocyte cytolysis following a tuberculin skin test. Proc. Soc. exp. Biol. (N. Y.) 73, 122–124 (1950).Google Scholar
  147. Fellinger, K., u. J. Schmid: Klinik und Therapie des chronischen Gelenkrheumatismus. Wien: Wilhelm Maudrich 1954.Google Scholar
  148. Findlay, L: The rheumatic infection in childhood. William Ward and Co. 1932.Google Scholar
  149. Finland, M: The present status of antibiotics in bacterial infections. Bull. N. Y. Acad. Med. 27, 199–220 (1951).PubMedGoogle Scholar
  150. Finland, M. W., H. Robey and H. Heimann: The effect of tonsillectomy on the occurrence and course of acute polyarthritis; analysis of 654 consecutive case histories. Amer. Heart J. 8, 343–356 (1933).Google Scholar
  151. Fischel, E. E: The role of allergy in the pathogenesis of rheumatic fever. Amer. J. Med. 7, 772–793 (1949).PubMedGoogle Scholar
  152. Fisher, J. H: Upper respiratory and middle ear infections; bacteriologic and experimental study. J. infect. Dis. 44, 33–43 (1929).Google Scholar
  153. Fisher, P. J., and R.A.Cooke: Passive cutaneous anaphylaxis (PC A) in the guinea pig. J. Allergy 28, 150–169 (1957).PubMedGoogle Scholar
  154. Florio, L., G. K. Lewis, G. Weiss and H. Olson: Tissue culture studies of cellular hypersensitivity in rheumatic fever. III. A reexamination of tuberculin hypersensitivity in tissue cultures by a study of the response to old tuberculin of human white blood cells and fibroblasts from human and guinea pig skin. J. Immunol. 80, 32–38 (1958).PubMedGoogle Scholar
  155. Florio, L., G. Weiss and G. K. Lewis: Tissue culture studies of cellular hypersensitivity in rheumatic fever. I. The response of human white blood cells to streptococci and to crude filtrates of streptococcal cultures. J. Immunol. 80, 12–25 (1958).PubMedGoogle Scholar
  156. Francisco, R: Rheumatic heart diseases in the tropics with special reference to its incidence in Puerto Rico. Clinica 5, 971–984 (1946).Google Scholar
  157. Freeman, V. J: Studies on the virulence of bacteriophage-infected strains of corynebacterium diphtheriae. J. Bact. 61, 675–688 (1951).PubMedGoogle Scholar
  158. Freund, J: Some aspects of active immunization. Annual Rev. Microbiol. 1, 291–308 (1947).Google Scholar
  159. Freund, J: The mode of action of immunologic adjuvants. Adv. Tuberc. Res. 7, 130–148 Basel/ New York: S. Karger 1956.Google Scholar
  160. Freund, J: Sensitization with organ specific antigens and the mechanism of enhancement of the immune response. J. Allergy 28, 18–28 (1957).PubMedGoogle Scholar
  161. Friou, G. J: Further observations of an inhibitor in human serums of the hyaluronidase produced by a strain of hemolytic streptococcus. J. infect. Dis. 84, 240–251 (1949).PubMedGoogle Scholar
  162. Friou, G. J., H. A. Wenner: On the occurrence in human serum of an inhibitory substance to hyaluronidase produced by a strain of hemolytic streptococcus. J. infect. Dis. 80, 185 bis 193 (1947).Google Scholar
  163. Fritz: Zur Aetiologie der Polyarthritis rheumatica. Z. klin. Med. 1, 229–231 (1880).Google Scholar
  164. Gell, P. G. H., and J. T. Hinde: Observations on the histology of the Arthus reaction and its relation to other known types of skin hypersensitivity. Internat. Arch. Allergy 5, 23–46(1954).Google Scholar
  165. Geller, W., u. F. J. Latjbenthal: Halbscitige Polyarthritis bei zentraler spastischer Lähmung. Dtsch. Arch. klin. Med. 194, 134–144 (1948).Google Scholar
  166. Gibian, H: Chemie, biologische Bedeutung und klinische Anwendung der Hyaluronidase. Angew. Chem. 63, 105–117 (1951).Google Scholar
  167. Gibson, H. J., and W. A. R. Thomson: Study of etiology of acute rheumatism, with special reference to relationship of hemolytic streptococcus to disease. Edinburgh med. J. 40, 93–116 (1933).Google Scholar
  168. and D. Stewart: The hemolytic streptococcus as a factor in the causation of acuteGoogle Scholar
  169. rheumatism. Arch. Dis. Childh. 8, 57–72 (1933).Google Scholar
  170. Gierhake, F. -W: Über eine Methode zum selektiven Nachweis hämolytischer Streptokokken beim Scharlach, sowie über Beobachtungen bei gleichzeitiger anaerober Bebrütung. Klin. Wschr. 1954, 292–294.Google Scholar
  171. Glaser, R. J., W. A. Thomas, S. I. Morse and J. E. Darnell: The incidence and pathogenesis of myocarditis in rabbits after group A streptococcal pharyngeal infections. J. exp. Med. 103, 173–187 (1956).PubMedGoogle Scholar
  172. Glynn, A. A., L. E. Glynn and E. J. Holborow: The secretor status of rheumatic-fever patients. Lancet 1956II, 759–762.Google Scholar
  173. Glynn, L. E., and E. J. Holborow: Conversion of tissue polysaccharides to auto-antigens by group A beta-haemolytic streptococci. Lancet 1952II, 449–451.Google Scholar
  174. Glynn, L. E., E. J. Holborow: Production of complete antigens from polysaccharide haptens by streptococci and other organisms. J. Path. Bact. 64, 775–783 (1952).PubMedGoogle Scholar
  175. Goldberger, E: The etiology and pathogenesis of rheumatic fever. Acta med. scand. 161, 347–359 (1958).PubMedGoogle Scholar
  176. Goldie, W., and G. J. Griffiths: Aetiological relation of streptococcus haemolyticus to “rheumatic” diseases. Brit. med. J. 1936 II, 755–757.Google Scholar
  177. Good, R. A., and D. Glick: Mucolytic enzyme systems. IX. Nonspecific hyaluronidase inhibitor in rheumatic fever. J. infect. Dis. 86, 38–45 (1950).PubMedGoogle Scholar
  178. Grant, R. T: After histories for ten years of 1000 men suffering from heart disease; study in prognosis. Heart 6, 275–483 (1933).Google Scholar
  179. Gray, F. G., R. W. Quinn and J. P. Quinn: A long-term survey of rheumatic and non- rheumatic families. Amer. J. Med. 13, 400–412 (1952).PubMedGoogle Scholar
  180. Green, C. A: Sensitivity of rheumatic subjects to streptococcal products. J. Path. Bact. 47, 337–344 (1938).Google Scholar
  181. Green, C. A: Researches into the aetiology of acute rheumatism. I. Rheumatic carditis: post-mortem investigation of nine consecutive cases. Ann. Rheumat. Dis. 1, 86–98 (1939).Google Scholar
  182. Griffith, F: The serological classification of streptococcus pyogenes. J. Hyg. 34, 542–584 (1934).Google Scholar
  183. Griffiths, G. J: Antihemolysin titres in chronic rheumatic and allied diseases. Lancet 1934 II, 251–252.Google Scholar
  184. Gros, H., u. H. Cullmann: Zur Herzbeteiligung beim chronischen Gelenkrheumatismus. Med. Klin. 1957, 888–892.Google Scholar
  185. Grün, L: Alte und neue Probleme der Staphylokokken. Erg. Mikrobiol. 31, 130–183 (1958).Google Scholar
  186. Gunnison, J. B., M. P. Luxen, J. R. Cummings and M.S.Marshall: Differentiation of hemolytic streptococci from various sources by group precipitin reaction and by biochemical tests. J. Bact. 39, 689–708 (1940).PubMedGoogle Scholar
  187. Guthof, O: Zahnbakteriologische Fragen im Zusammenhang mit Wurzelbehandlung und Herdinfektion. Zahnärztl. Rdsch. 62, 190–193 (1953).Google Scholar
  188. Guthof, O: Über pathogene vergrünende Streptokokken. Zbl. Bakt., I. Abt. Orig. 166, 553–564 (1956).Google Scholar
  189. Gutzeit, K., u. G. W. Parade: Fokalinfektion. Ergebn. inn. Med. Kinderheilk. 57, 613 bis 722 (1939).Google Scholar
  190. Haas, E: On mechanism of invasion; antinvasin I, enzyme in plasma. J. biol. Chem. 163, 63–88 (1946).PubMedGoogle Scholar
  191. Haase, K.-E: Tuberkulin und Tuberkulindiagnostik. Ergebn. inn. Med. Kinderheilk. 8, 367–456 (1957).Google Scholar
  192. Haig-Brown, C: Tonsillitis in adolescents. London: Bailliere, Tindal and Cox 1886.Google Scholar
  193. Halbert, S. P., L. Swick and C. Sonn: Use of precipitin analysis in agar for study of human streptococcal infections; Oudin technic. J. exp. Med. 101, 539–556 (1955)–Ouchter- lony and Oakley technics. J. exp. Med. 101, 557–576 (1955).Google Scholar
  194. Hangarter, W: Das Erbbild der rheumatischen und chronischen Gelenkerkrankungen. In Der Rheumatismus, herausgeg. von R. Schoen. Bd. 13. Dresden: Theodor Steinkopff 1939.Google Scholar
  195. Hanhart, E: Erbpathologie der sog. Entartungszeichen, der allergischen Diathese und der rheumatischen Erkrankungen. In Handbuch der Erbbiologie des Menschen, herausgeg. von K. H. Bauer, E. Hanhart, G. Just, J. Lange. II. Berlin: Springer 1940.Google Scholar
  196. Hanks, J. H: The mechanism of tuberculin hypersensitiveness. J. Immunol. 28, 105–121 (1935).Google Scholar
  197. Hansen, A. E: Rheumatic recrudescence. Diagnosis and prevention. J. Pediat. 28, 296–308 (1946).PubMedGoogle Scholar
  198. Hansen, K: Klinische Diagnostik bei allergischen Krankheiten. In Allergie, herausgeg. von K. Hansen. S. 244–272. Stuttgart: Georg Thieme 1957.Google Scholar
  199. Hardgrove, M., L. Whittier, and E. R. Smith: Rheumatic fever in the isthmus of Panama. J. Amer. med. Ass. 130, 488–490 (1946).Google Scholar
  200. Hardin, R. A., R. W. Quinn and R. C. Avery: A survey of hemolytic streptococci from patients with rheumatic fever, glomerulo-nephritis, pharyngitis and the carrier state. J. infect. Dis. 99, 84–89 (1956).PubMedGoogle Scholar
  201. Harris, C. H. S: Present conceptions of etiologv of rheumatic fever. St. Bart’s Hosp. J. 42, 107–111 (1935).Google Scholar
  202. Harris, S., and T. N. Harris: The measurement of neutralizing antibodies to streptococcal hvaluronidase by a turbidimetric method. J. Immunol. 63, 233–247 (1949).PubMedGoogle Scholar
  203. Harris, T. N: Studies in the relation of the hemolytic streptococcus to rheumatic fever. III. Complement fixation versus streptococcal nucleoproteins with the sera of patients with rheumatic fever and others. J. exp. Med. 87, 57–70 (1948).PubMedGoogle Scholar
  204. Harris, T. N., W. B. Abrams, and S. Harris: Viscosimetric measurement of streptococcal antihyaluroni- dase: comparison with titers obtained by turbidimetry. J. infect. Dis. 86, 122–131 (1950).PubMedGoogle Scholar
  205. Harris, T. N., S. Friedman: Relation of the hemolytic streptococcus to rheumatic fever. IV. Effect of streptococcic spreading factor in rheumatic patients and others. Amer. J. Dis. Child. 77, 561–575 (1949).Google Scholar
  206. Harris, T. N., D. C. McLean: Determination of some streptococcal antibody titers and acute phase reactants in patients with chorea. Pediatrics 21, 13–21 (1958).PubMedGoogle Scholar
  207. Harris, T. N., J. Tang: The appearance of new cardiac murmurs in patients having rheumatic heart disease with no concomitant evidence of rheumatic activity. Amer. J. Med. 23, 748–760 (1957).PubMedGoogle Scholar
  208. Harris, T. N., S. Harris: Studies in the relation of the hemolytic streptococcus to rheumatic fever. V. Streptococcal anti-hyaluronidase (mucin-clot-prevention) titers in the sera of patients with rheumatic fever, streptococcal infection, and others. Amer. J. med. Sci. 217, 174 bis 186 (1949).Google Scholar
  209. Harris, T. N: Turbidimetric measurement of streptococcal antihyaluronidase in the sera of patients with streptococcal infection and rheumatic fever. J. Immunol. 63, 249–260 (1949).PubMedGoogle Scholar
  210. Harris, T. N., R. L. Nagle: Studies in the relation of the hemolytic streptococcus to rheumatic fever. VI. Comparison of streptococcal antihyaluronidase with antibodies to other streptococcal antigens in the serum of patients with rheumatic fever and acute streptococcal infection: Mucin clot prevention test. Pediatrics 3, 482–503 (1949).PubMedGoogle Scholar
  211. Harris, T. N., C. A. Ogburn: Gel-precipitation of streptococcal culture supernates with sera of patients with rheumatic fever and streptococcal infection. Proc. Soc. exp. Biol. (N. Y.) 90, 39–45 (1955).Google Scholar
  212. Harris, T. N., H. L. Needleman, S.Harris and S.Friedman: Antistreptolysin and streptococcal antihyaluronidase titers in sera of hormone-treated and control patients with acute rheumatic fever. Pediatrics 17, 29–35 (1956).PubMedGoogle Scholar
  213. Hartl, H: Klinische Beobachtungen bei Funduliformis-Infektionen in der Gynäkologie. Schweiz, med. Wschr. 1950, 1136–1139.Google Scholar
  214. Hartley, P., and M. Lewellyn Smith: A proposed international standard for staphylococcus antitoxin. Quart. Bull. Health Org. League of Nat. Spec. No. Jan. 1935, 68–110.Google Scholar
  215. Hartmann, F: Serologische Reaktionen beim Rheumatismus. Z. Rheumaforsch. 16, 150–182 (1957).PubMedGoogle Scholar
  216. Haxthausen, H: Pathogenesis of allergic eczema, illustrated by transplantation experiments. Acta derm.-venereol. (Stockh.) 31, 42–45 (1951).Google Scholar
  217. Hayman, J. M., and J. W. Martin: Acute nephritis. Review of 77 cases. Amer. J. med. Sci. 200, 505–514 (1940).Google Scholar
  218. Hill, A. M., and H. M. Butler: Haemolytic streptococcal infections following childbirth and abortion; clinical features, with special reference to infections due to streptococci of groups other than A. Med. J. Aust. 1, 293–299 (1940).Google Scholar
  219. Hodge, B. E., and H. E. Swift: Varying haemolytic and constant combining capacity of streptolysins; influence of testing for antistreptolysins. J. exp. Med. 58, 277–287 (1933).PubMedGoogle Scholar
  220. Hoff, F: [1] Pathogenese und Therapie des chronischen Gelenkrheumatismus. Verh. dtsch. orthop. Ges. 1953, 49–67.Google Scholar
  221. Hoff, F: [2] Fieber, unspezifische Abwehrvorgänge, unspezifische Therapie. Stuttgart: Georg Thieme 1957.Google Scholar
  222. Holborow, E. J., and J. C. Isdale: Antistreptolysin response in acute rheumatic fever in children. Lancet 1956 I, 649–651.Google Scholar
  223. Holbrook, W. P: Rheumatic fever. Hygeia, Chicago 25, 344 (1947).Google Scholar
  224. Horsfall, F. L: Virus Diseases. Ithaca, N. Y.: Cornell Univ. Press 1943.Google Scholar
  225. Horster, H: Das Sanarelli-Shwartzman-Hangersche Phänomen und Scine klinische Bedeutung. Klin. Wschr. 1938, 1610–1613.Google Scholar
  226. Humphrey, J. H., and W. Pagel: The tissue response to heat-killed streptococci in the skin of normal subjects, and in persons with rheumatic fever, rheumatoid arthritis, subacute bacterial endocarditis and erythema nodosum. Brit. J. exp. Path. 30, 282–288 (1949).PubMedGoogle Scholar
  227. Hutchinson, R. J: Pathogenicity of group C (Lancefield) haemolytic streptococcus. Brit, med. J. 1946 II, 575–576.Google Scholar
  228. Ihm, P: Ein Konfidenzbereich für den Erwartungswert eines Mittelwertpaares. Z. indukt. Abstamm.- u. Vererb.-Lehre 80, 54–60 (1954).Google Scholar
  229. Inderbitzin, Th: Das Problem der allergischen Reaktionsmechanismen. Internat. Arch. Allergy 9, 146–188 (1956).Google Scholar
  230. Ipsen, J: A standard for antistreptolysin 0 of human serum, and its practical application. Acta path, microbiol. scand. 21, 203–213 (1943).Google Scholar
  231. Irvine-Jones, E: Acute rheumatism as a familial disease. Amer. J. Dis. Child. 45, 1184–1195 (1933).Google Scholar
  232. Jaccard, G: Beobachtungen über die Wirkung von Tuberkulin auf die Leukozyten tuber- kulinempfindlicher Menschen. Int. Arch. Allergy 8, 97–102 (1956).PubMedGoogle Scholar
  233. Johnson, A. G., S. Gaines and M. Landy: Studies on the 0 antigen of salmonella typhosa. V. Enhancement of antibody response to protein antigens by the purified lipopolysaccha- ride. J. exp. Med. 103, 225–246 (1956).Google Scholar
  234. Jones, T. D: The diagnosis of rheumatic fever. J. Amer. med. Ass. 126, 481–484 (1944).Google Scholar
  235. Jones, T. D.,. D. White, C. F. Roche, J. J. Perdue and H. A. Ryan: Transportation of rheumatic fever patients to a subtropical climate. J. Amer. med. Ass. 109, 1308–1309 (1937).Google Scholar
  236. Julianelle, L. A., and M. C. Morris: Reactions of rabbits to intracutaneous injections of pneumococci and their products; interrelationship of hypersensitiveness to pneumococcus and streptococcus. J. exp. Med. 55, 867–876 (1932).PubMedGoogle Scholar
  237. Kaiser, A. D: Skin reactions in rheumatic fever (Birkhaug Test) studies in 801 persons with the toxic filtrate produced by the non methemoglobin-forming streptococcus isolated from cases of rheumatic fever. J. infect. Dis. 42, 25–30 (1928).Google Scholar
  238. Kaiser, A. D:Factors that influence rheumatic disease in children. J. Amer. med. Ass. 103, 886–891 (1934).Google Scholar
  239. Kaiser, A. D: Significance of the tonsils in development of the child. J. Amer. med. Ass. 115, 1151–1156 (1940).Google Scholar
  240. Kalbak, K: Experimentelle og kliniske Undersogelser over 0-Streptolysin og Forekomsten af O ntistreptolysin i Serum. Kopenhagen: Ejnar Munksgaard 1942.Google Scholar
  241. Kaiser, A. D: The antistreptolysin-reaction, I: Technique. Kopenhagen: The State Serum Institute 1947.Google Scholar
  242. Kannenberg: Ueber Nephritis bei acuten Infectionskrankheiten. Z. klin. Med. 1, 506–512 (1880).Google Scholar
  243. Kaplan, M. H: Studies of streptococcal fibrinolysis. I. The dissimilarity of serum protease and trypsin as indicated by the separate specifities of their kinases, fibrinolysin and enterokinase. J. clin. Invest. 25, 331–336 (1946).Google Scholar
  244. Kaplan, M. H: Localization of streptococcal antigens in tissues. I. Histologic distribution and persistence of M protein, types 1, 5, 12, and 19 in the tissue of the mouse. J. exp. Med. 107, 341–352 (1958).Google Scholar
  245. Karelitz, S., and A. Glorig: Studies in the specific mechanism of serum sickness. III. Passive sensitization with antibody contained in serum sickness convalescent serum. J. Immunol. 47, 121–131 (1943).„Google Scholar
  246. Kaufmann, O., u. E. Scheerer: Über die Erblichkeit des akuten Gelenkrheumatismus. Z. menschl. Vererb.- u. Konstit.-Lehre 21, 687–696 (1938).Google Scholar
  247. Kellner, A., A. W. Bernheimer, A. S. Carlson and E. B. Freeman: Loss of myocardial contractility induced in isolated mammalian hearts by streptolysin 0. J. exp. Med. 104, 361–373 (1956).PubMedGoogle Scholar
  248. Kellner, A., Th. Robertson: [1] Selective necrosis of cardiac and skeletal muscle induced experimentally by means of proteolytic enzyme solutions given intravenously. J. exp. Med. 99, 387–403 (1954).PubMedGoogle Scholar
  249. Kellner, A:2] Myocardial necrosis in animals by means of crystalline streptococcal proteinase.Google Scholar
  250. J. exp. Med. 99, 495–503 (1954).Google Scholar
  251. Kempe, C. H., R. W. Olmsted and E. C. Curnen: Outbreak of acute nephritis in adolescent school boys. Pediatrics 8, 393–405 (1951).PubMedGoogle Scholar
  252. Kilbourne, E. D., and J. Ph. Loge: The comparative effect of continuous and intermittent penicillin therapy on the formation of antistreptolysin in hemolytic streptococcal pharyngitis. J. clin. Invest. 27, 418–424 (1948).Google Scholar
  253. Kirby, W. M. M: Hemagglutination reaction in streptococcal infections and acute rheumatic fever. Proc. Soc. exp. Biol. (N. Y.) 78, 519–522 (1951).Google Scholar
  254. Kirchheimer, W. F., A. R. Hess and R. G. Spears: Attempts at passive transfer of tuberculin type of sensitivity with living granulocytes. Amer. Rev. Tuberc. 64, 516–519 (1951).Google Scholar
  255. Kleinman, H: Epidemic acute glomerulonephritis at Red Lake. Minnesota Med. 37, 479 bis 483 (1954).Google Scholar
  256. Kleinschmidt, H: Der Scharlach. In: Die ansteckenden Krankheiten, herausgeg. von M. Gundel. 3. Aufl., S. 504–517. Leipzig: Georg Thieme 1944.Google Scholar
  257. Klinge, F: Die Eiweißüberempfindlichkeit (Gewebsanaphylaxie) der Gelenke. Beitr. path. Anat. 83, 185–216 (1929).Google Scholar
  258. Klinge, F: Der Rheumatismus; pathologisch-anatomische und experimentell-pathologische Tatsachen und ihre Auswertung für das ärztliche Rheuma-Problem. Ergebn. allg. Path. 27, 1–351 (1933).Google Scholar
  259. Köhler, W: Streptolysine und Antistreptolysin-Reaktion. Leipzig: Johann Ambrosius Barth 1957.Google Scholar
  260. Kourilsky, R., G. Decroix et P. Ganter: Études sur l’allergie tuberculinique, la transmission de l’allergie. Rev. immunol. 16, 333–372 (1952).Google Scholar
  261. Kreidberg, M. B., W. Dameshek and R. Latorraca: Acute vascular (Schönlein-Henoch) purpura–an immunologie disease. New Engl. J. Med. 253, 1014–1018 (1955).Google Scholar
  262. Kronenberger, A: Experimentelle Untersuchungen zum Nachweis von Antikörpern gegen nicht-hämolytische Strrptokokken im menschlichen Serum. Diss. rankfurt a. M. 1955.Google Scholar
  263. Kuhns, W. J., and M. McCarty: Studies of diphtheria antitoxin in rheumatic fever subjects. Analysis of reactions to the Schick test and of antitoxin responses following hyperimmu- nization with diphtheria toxoid. J. clin. Invest. 33, 759–767 (1954).PubMedGoogle Scholar
  264. Klinge, F., A. M. Pappenheimer: Immunochemical studies of antitoxin produced in normal and allergic individuals hyperimmunized with diphtheria toxoid. I. Relationship of skin sensitivity to purified diphtheria toxoid to the presence of circulating, non-precipitating antitoxin. J. exp. Med. 95, 363–374 (1952). II. A comparison between the immunological properties of precipitating and non-precipitating (skin sensitizing) antitoxins. J. exp. Med. 95, 375–392 (1952).Google Scholar
  265. Kuttner, A. G., and E. Krumwiede: Observations on the effect of streptococcal upper respiratory infections on rheumatic children: a three year study. J. clin. Invest. 20, 273 bis 287 (1941).Google Scholar
  266. Kuttner, A. G., T. E. Lenert: The occurrence of bacteriostatic properties in the blood of patients after recovery from streptococcal pharyngitis. J. clin. Invest. 23, 151–161 (1944).PubMedGoogle Scholar
  267. Küster, F., u. K. Kroeger: Weitere Untersuchungen über den Nekrosefaktor im Serum beim rheumatischen Fieber. Klin. Wschr. 1957, 1076–1079.Google Scholar
  268. Lancefield, R. C: Antigenic complex of streptococcus haemolyticus; anaphylaxis with 2 non-type-specific fractions. J. exp. Med. 47, 843–855 (1928).PubMedGoogle Scholar
  269. Lancefield, R. C: Antigenic complex of streptococcus haemolyticus; anaphylaxis with type-specific substance. J. exp. Med. 47, 857–875 (1928).PubMedGoogle Scholar
  270. Lancefield, R. C: A serological differentiation of human and other groups of hemolytic streptococci. J. exp. Med. 57, 571–595 (1933).PubMedGoogle Scholar
  271. Lancefield, R. C: Specific relationship of cell composition to biological activity of hemolytic streptococci. Harvey Lect. 36, 251 (1940–41).Google Scholar
  272. Lancefield, R. C: Cellular constituents of group A streptococci concerned in antigenicity and virulence. In Streptococcal infections. Edited by M. McCarty. S. 3–18. New York: Columbia University Press 1954.Google Scholar
  273. Lancefield, R. C: Differentiation of group A streptococci with a common R antigen into three serological types, with special reference to the bactericidal test. J. exp. Med. 106, 525–544 (1957).PubMedGoogle Scholar
  274. Landsteiner, K., and M.W.Chase: Experiments on transfer of cutaneous sensitivity to simple compounds. Proc. Soc. exp. Biol. (N. Y.) 49, 688–690 (1942).Google Scholar
  275. Laporte, A., et H. Brocard: La réaction de floculation du sérum en présence d’un extrait alcoolique microbien dans les infections à Bacillus funduliformis. C. R. Soc. Biol. (Paris) 131, 4–7 (1939).Google Scholar
  276. Larson, D. L: Current views on pathogenesis and therapy of rheumatic fever. Amer. J. Med. 22, 422–436 (1957).Google Scholar
  277. Lasègue: Zit. nach R. Schoen u. W. Tischendorf.Google Scholar
  278. Lautenbach, E., u. G. Linzenmeier: Zur Frage der Bakteriämie nach Zahnextraktionen. Dtsch. zahnärztl. Z. 12, 980–992 (1957).Google Scholar
  279. Lawrence, H. S: The cellular transfer of cutaneous hypersensitivity to tuberculin in man. Proc. exp. Biol. (N. Y.) 71, 516–522 (1949).Google Scholar
  280. Lawrence, H. S: The cellular transfer in humans of delayed cutaneous reactivity to hemolytic streptococci. J. Immunol. 68, 159–178 (1952).PubMedGoogle Scholar
  281. Lawrence, H. S: The delayed type of allergic inflammatory response. Amer. J. Med. 20, 428–447 (1956).PubMedGoogle Scholar
  282. Lawrence, H. S., A. M. Pappenheimer: Transfer of delayed hypersensitivity to diphtheria toxin in man. J. exp. Med. 104, 321–335 (1956).PubMedGoogle Scholar
  283. Lawrence, W. St: The familial association of cardiac disease, acute rheumatic fever and chorea. J. Amer. med. Ass. 79, 2051–2055 (1922).Google Scholar
  284. Legler, F: Erfahrungen mit der Antistreptolysinreaktion. Z. Immunforsch. 112, 99 bis 121 (1955).Google Scholar
  285. Lindenmann, J: Die Staphylokokkeninfektionen. In: Die Infektionskrankheiten des Menschen und ihre Erreger, herausgeg. von A. Grumbach und W. Kikuth. I, S. 413–444. Stuttgart: Georg Thieme 1958.Google Scholar
  286. Lithander, A: Method of production staphylococcic toxin. Acta path, microbiol. scand. 27, 764–767 (1944).Google Scholar
  287. Lodenkämper, H., u. G. Stienen: Zur Therapie anaerober Infektionen. Dtsch. med. Wschr. 1956, 1226–1231.Google Scholar
  288. Loeb, E. N., J. D. Lyttle, D. Seegal, and E. L. Jost: On the permanence of recovery in acute glomerulonephritis. J. clin. Invest. 17, 623–629 (1938).PubMedGoogle Scholar
  289. Longcope, W. T: The production of experimental nephritis by repeated protein intoxication. J. exp. Med. 18, 678–703 (1913).PubMedGoogle Scholar
  290. Longcope, W. T: The effect of repeated injections of foreign protein on the heart muscle. Arch, intern. Med. 15, 1079–1084 (1915).Google Scholar
  291. Longcope, W. T: Some observations on the course and outcome of hemorrhagic nephritis. Internat. Clin. 1, 1–16 (1938).Google Scholar
  292. Loomis, E. E., C. George and A.Ryder: Fibrinolysin: nomenclature, unit, assay, preparation and properties. Arch. Biochem. 12, 1–5 (1947).PubMedGoogle Scholar
  293. Lou, H: Streptoc. fibrinolyse (dänisch). Kopenhagen 1941 ; zit. nach H. Schmidt (5).Google Scholar
  294. Lyttle, J. D., D. Seegal and E. L. Jost: Cutaneous reactions with hemolytic streptococcus nucleoprotein in persons with scarlet fever. Amer. J. Dis. Child. 50, 573–580 (1935).Google Scholar
  295. Mackenzie, G. M., and F. M. Hanger: Allergic reactions to streptococcus antigens. J. Immunol. 13, 41–58 (1927).Google Scholar
  296. Madinaveitia, J., and T. H. H. Quibbel: Studies on diffusing factors; action of testicular extracts on viscosity of vitreous humor preparations. Biochem. J. 34, 625–631 (1940).PubMedGoogle Scholar
  297. Madsen, T., and K. Kalbak: Investigations on rheumatic fever subsequent to some epidemics of septic sore throat (especially milk epidemics). Acta path, microbiol. scand. 17, 305–327 (1940).Google Scholar
  298. Manser, R. W. E., and M. M. Wilson: An epidemic of haemolytic streptococcal (group A) infection associated with a considerable incidence of acute nephritis. Med. J. Aust. 2, 339–341 (1952).PubMedGoogle Scholar
  299. Mantle, A: Etiology of rheumatism considered from a bacterial point of view. Brit. med. J. 1887 I, 1381–1384.Google Scholar
  300. Marko Witz, M: Observations on an epidemic of streptococcal infections and recurrences of rheumatic fever among children treated with penicillin. Pediatrics 20, 257–267 (1957).Google Scholar
  301. Maxted, W. R: Preparation of streptococcal extracts for Lancefield grouping. Lancet 1948 II, 255–256.Google Scholar
  302. Maxted W. R: The indirect bactericidal test as a means of identifying antibody to the M antigen of streptococcus pyogenes. Brit. J. exp. Path. 37, 415–422 (1956).PubMedGoogle Scholar
  303. May, K. J., and R. S. Weiser: The tuberculin reaction. J. Immunol. 77, 34–39 (1956).PubMedGoogle Scholar
  304. McCarty, M: The inhibition of streptococcal desoxyribonuclease by rabbit and human antisera. J. exp. Med. 90, 543–553 (1949).PubMedGoogle Scholar
  305. McCarty, M: The biology of group A hemolytic streptococci. In Rheumatic fever. Edited by L. Thomas. S. 61–71. Minneapolis: University of Minnesota Press 1952.Google Scholar
  306. McCarty, M: The immune response in rheumatic fever. In Rheumatic fever. Edited by L. Thomas. S. 136–149. Minneapolis: University of Minnesota Press 1952.Google Scholar
  307. McCarty, M: Present state of knowledge concerning pathogenesis and treatment of rheumatic fever. Bull. N. Y. Acad. Med. 28, 307–320 (1952).PubMedGoogle Scholar
  308. McCarty, M: The antibody response to streptococcal infections. In Streptococcal Infections. Edited by M. McCarty. S. 130–142. New York: Columbia University Press 1954.Google Scholar
  309. McCarty, M: Nature of rheumatic fever. Circulation 14, 1138–1145 (1956).PubMedGoogle Scholar
  310. McClean, D: Studies on diffusing factors. 2. Methods of assay of hyaluronidase and their correlation with skin diffusing activity. Biochem. J. 37, 169–177 (1943).PubMedGoogle Scholar
  311. McClean, D., H. J. Rogers, and B. W. Williams: Early diagnosis of wound infection. Lancet 1943 I, 355–360.Google Scholar
  312. McCorkle, L. P., R. G. Hodges, G. F. Badger, J. H. Dingle and W. S. Jordan: A study in a group of Cleveland families. VIII. Relation of tonsillectomy to incidence of common respiratory diseases in children. New Engl. J. Med. 252, 1066–1069 (1955).Google Scholar
  313. McCrae, J: A study of eight hundred and fifty cases of scarlet fever with a more particular consideration of seventy-one fatal cases. Canad. med. Ass. J. 1, 293 (1911); zit. nach Ch. H. Rammelkamp (5).Google Scholar
  314. McKinley, E. B: A geography of disease: a preliminary survey of the incidence and distribution of tropical and certain other diseases. Amer. J. trop. Med. 15 (Suppl.), 3–489 (1935).Google Scholar
  315. McMillan, J. C: Seventy-eight hundred scarlet fever patients. U. S. Nav. Med. Bull. 46, 89–91 (1946).PubMedGoogle Scholar
  316. Menzer, A: Serumbehandlung bei acutem und chronischem Gelenkrheumatismus. Z. klin. Med. 47, 109–152 (1902).Google Scholar
  317. Meyer, K: The biological significance of hyaluronic acid and hyaluronidase. Physiol. Rev. 27, 335–359 (1947).PubMedGoogle Scholar
  318. Meyer, K: The chemistry of the mesodermal ground substances. Harvey Lect. (1955–1956) Ser. 51, 88–112 (1957).Google Scholar
  319. Miescher, P: Bakteriell-allergische Yasculitiden als Ursache von Organerkrankungen. Schweiz. med. Wschr. 1957, 1339–1347.Google Scholar
  320. Miescher, P., K. O. Vorlaender: Immunopathologie in Klinik und Forschung und das Problem der Autoantikorper. Stuttgart: Georg Thieme 1957.Google Scholar
  321. Miller, J. M., S. Kibrick and B. F. Mass ell: Antibody response to non-streptococcal antigens as related to rheumatic fever susceptibility. J. clin. Invest. 32, 691–695 (1953).PubMedGoogle Scholar
  322. Miller, J. M., J. H. Yaughan and C. B. Favour: The role of complement in the lysis of leucocytes by tuberculoprotein. Proc. Soc. exp. Biol. (N. Y.) 71, 592–597 (1949).Google Scholar
  323. Milstone, H: A factor in normal human blood which participates in streptococcal fibrinolysis. J. Immunol. 42, 109–116 (1941).Google Scholar
  324. Moen, J. K: Tissue culture studies on bacterial hypersensitivity. II: Reactions of tissues from guinea pigs infected with group C hemolytic streptococci. J. exp. Med. 64, 355 bis 368 (1938).Google Scholar
  325. Moen, J. K., H. F. Swift: Tissue culture studies on bacterial hypersensitivity. I: tuberculin sensitive tissue. J. exp. Med. 64, 339–353 (1936).PubMedGoogle Scholar
  326. Moore, D. H., and T. N. Harris: Occurrence of hyaluronidase inhibitors in fractions of electrophoretically separated serum. J. biol. Chem. 179, 377–381 (1949).PubMedGoogle Scholar
  327. Morris, A. J., F. J. Catanzaro, R. Chamovitz, Ch. A. Stetson and Ch. H. Rammelkamp: The relative importance of antigen and antibody in the pathogenesis of rheumatic fever. Clin. Res. Proc. 2, 75. (1954).Google Scholar
  328. Morris, A. J., R. Chamovitz, F. J. Catanzaro and Ch. H. Rammelkamp: Prevention of rheumatic fever by treatment of previous streptococcal infections. Effect of sulfadiazine. J. Amer. med. Ass. 160, 114–116 (1956).Google Scholar
  329. Mortimer, E. A., and Ch. H. Rammelkamp: Prophylaxis of rheumatic fever. Circulation 14, 1144–1152 (1956).PubMedGoogle Scholar
  330. Mote, J. R., and T. D. Jones: Studies of hemolytic streptococcal antibodies in control groups, rheumatic fever, and rheumatoid arthritis. I. The incidence of antistreptolysin “O”, antifibrinolysin, and hemolytic streptococcal precipitating antibodies in the sera of urban control groups. J. Immunol. 41, 35–60 (1941).Google Scholar
  331. Mote, J. R., and D. T. Jones: II. The frequency of antistreptolysin “0”, antifibrinolysin, and precipitating-antibody responses in scarlet fever, hemolytic streptococcal infections, and rheumatic fever. J. Immunol. 41, 61–85 (1941).Google Scholar
  332. Mote, J. R: III. The magnitude of antistreptolysin “0”, antifibrinolysin, and precipitating-antibody responses; the persistence of the antibodies, and variations in antistreptolysin “0” curves in scarlet fever, hemolytic streptococcal infections, and rheumatic fever. J. Immunol. 41, 87–118 (1941).Google Scholar
  333. Murphy, G. E: The evolution of our knowledge of rheumatic fever; an historical survey with particular emphasis on rheumatic heart disease. Bull. Hist. Med. 14, 123–147 (1943).Google Scholar
  334. Murphy, G. E: Evidence that Aschoff bodies of rheumatic myocarditis develop from injured myofibers. J. exp. Med. 95, 319–331 (1952).PubMedGoogle Scholar
  335. Murphy, G. E: The histopathology of rheumatic fever: A critical review. In Rheumatic fever. Edited by L. Thomas. S. 28–51. Minneapolis: University of Minnesota Press 1952.Google Scholar
  336. Murphy, G. E., H. F. Swift: Induction of cardiac lesions, closely resembling those of rheumatic fever, in rabbits following repeated skin infections with group A streptococci. J. exp. Med. 89, 687–698 (1949).PubMedGoogle Scholar
  337. Murphy, G. E: The induction of rheumatic-like cardiac lesions in rabbits by repeated focal infections ith group A streptococci. J. exp. Med. 91, 485–498 (1950).PubMedGoogle Scholar
  338. Müller, F: Akute virusbedingte Erkältungskrankheiten. Dtsch. med. Wschr. 1958, 1058 bis 1061 u. 1096–1097.Google Scholar
  339. Müller, F. von: Über den Rheumatismus. Münch, med. Wschr. 1933, 1–5 u. 49–54.Google Scholar
  340. Myers, W. K., C. S. Keefer and T. W. Oppel: Skin reactions to nucleoprotein of streptococcus scarlatinae in patients with rheumatoid arthritis and rheumatic fever. J. clin. Invest. 12, 279–289 (1933).PubMedGoogle Scholar
  341. Netzsch, H: Katamnestische Beurteilung der Tonsillektomie beim kindlichen Rheumatismus. Münch, med. Wschr. 1952, 971–975.Google Scholar
  342. Newsholme, A: The Milroy Lectures on the natural history and affinities of rheumatic fever; a study in epidemiology. Lancet 1895 I, 589; 657.Google Scholar
  343. Nichol, E. S: Rheumatic heart disease in southern Florida; incidence and clinical notes. Amer. Heart J. 9, 63–71 (1933).Google Scholar
  344. Nichol, E. S: Geographic distribution of rheumatic fever and rheumatic heart disease in the United States. J. Lab. clin. Med. 21, 588–596 (1936).Google Scholar
  345. Osman, A. A., H. G. Close and H. Carter: Studies in Bright’s disease, No. VIII. Observations on the aetiology of scarlatinal nephritis. Guy’s Hosp. Rep. 83, 360–386 (1933).Google Scholar
  346. Ott, V. R: Zur schweizerischen Rheuma-Klassifikation. Z. Rheumaforsch. 12, 65–70 (1953).PubMedGoogle Scholar
  347. Ovary, Z., and G. Biozzi: Passive sensitization of the skin of the guinea pig with human antibody. Internat. Arch. Allergy 5, 241–245 (1954).Google Scholar
  348. Packalen, Th: Non-specific antistreptolysin reactions and serum (or pleural exsudate) cholesterol. J. Bact. 56, 143–156 (1948).Google Scholar
  349. Nichol, E. S: Beta-haemolytic streptococci in throat and antistreptolysin titre. Acta path, microbiol. scand. 26, 568–576 (1949).Google Scholar
  350. Nichol, E. S., S. Bergqvist: Staphylococci in throat and nose and antistaphylolysin titre. Acta med. scand. 127, 291–312 (1947).Google Scholar
  351. Padovcova, H., V. Rejholece, F. Sud a and V. Wagner: Immunologic reactivity in rheumatic fever. Ann. paediat. (Basel) 187, 351–359 (1956).Google Scholar
  352. Palmer, C. E., and S. Nissen-Meyer: Research contributions of BCG vaccination programs.Google Scholar
  353. I. Tuberculin allergy as a family trait. Publ. Health Rep. (Wash.) 66, 259–276 (1951).Google Scholar
  354. Pappenheimer, A. M: Use of diphtheria toxin and toxoid in the study of immediate andGoogle Scholar
  355. delayed hypersensitivity in man. J. Immunol. 75, 259–264 (1955).Google Scholar
  356. Parade, G. W: Problematik der Diagnostik der Herderkrankungen. In Diagnose der Herderkrankungen. Herausgeg. von Deutsche Arbeitsgemeinschaft für Herdforschung und Herdbekämpfung. S. 21–30. München: Carl Hanser 1953.Google Scholar
  357. Paul, J. R: Epidemiology of rheumatic fever. Amer. J. Med. 2, 66–75 (1947).PubMedGoogle Scholar
  358. Paul, J. R., G. L. Dixon: Climate and rheumatic heart disease: a survey among American Indian school children in northern and southern localities. J. Amer. med. Ass. 108, 2096–2100 (1937).Google Scholar
  359. Pels Leusden, F., u. G. Blitz: Weitere bakteriologische Untersuchungsergebnisse anläßlich der Pinneberger Scharlach-Milchepidemie. Z. Hyg. 121, 260–275 (1938).Google Scholar
  360. Perry, W. D., A. C. Siegel and Ch. H. Rammelkamp: Transmission of group A streptococci. I. The role of contaminated dust. Amer. J. Hyg. 66, 96–101 (1957).Google Scholar
  361. Perry, W. D: Transmission of group A streptococci.I. The role of contaminated bedding. Amer. J. Hyg. 66, 85–95 (1957).PubMedGoogle Scholar
  362. Pfeiffer, E. F., u. H. E. Brtjch: Die Autoallergic in der Pathogenese der diffusen Glomerulo- Nephritis. Ergebn. inn. Med. Kinderheilk. 4, 669–705 (1953).Google Scholar
  363. Pike, R. M: An enrichment broth for isolating hemolytic streptococci from throat swabs. Proc. Soc. exper. Biol. (N. Y.) 57, 186–187 (1944).Google Scholar
  364. Pike, R. M: The isolation of hemolytic streptococci from throat swabs. Amer. J. Hyg. 41, 211–220 (1945).Google Scholar
  365. Pike, R. M: A study of group A streptococci from healthy carriers with particular attention to mucoid Polysaccharid production. J. infect. Dis. 79, 148–155 (1946).PubMedGoogle Scholar
  366. Pike, R. M: Streptococcal hyaluronic acid and hyaluronidase. J. infect. Dis. 83, 1–11 (1948).PubMedGoogle Scholar
  367. Pirquet, C. von: Allergie. Münch, med. Wschr. 1906, 1457–1458.Google Scholar
  368. Pirquet, C. von: Allergie. Ergebn. inn. Med. Kinderheilk. 1, 420–464 (1908).Google Scholar
  369. Pirquet, C. von:: Die Serumkrankheit. Wien: F. Deuticke 1905.Google Scholar
  370. Plummer, H: Serological and biochemical study of hemolytic streptococci. J. Immunol. 42, 91–107 (1941).Google Scholar
  371. Powers, G. F., and P. L. Boisvert: Age as a factor in streptococcosis. J. Pediat. 25, 481 bis 504 (1944).Google Scholar
  372. Portier, P., Ch. Richet: De l’action anaphylactique de cartains venins. C. R. Soc. Biol. (Paris) 54, 170–172 (1902).Google Scholar
  373. Prausnitz, C: The passive transfer of allergy. Internat. Arch. Allergy 6, 260–269 (1955).Google Scholar
  374. Prausnitz, C., H. Küstner: Studien über die Überempfindlichkeit. Zbl. Bakt., I. Abt. 86, 160 bis 169 (1921).Google Scholar
  375. Prévôt, A. R: Manuel de classification et de détermination des bactéries anaérobies. 2e éd. Paris: Masson et Cie 1948.Google Scholar
  376. Prévôt, A. R: Biologie des maladies dues aux anaérobies. Paris: Éditions médicales Flammarion 1955.Google Scholar
  377. Pribram, A: Der akute Gelenkrheumatismus. Wien: A. Holder 1899.Google Scholar
  378. Quinn, R. W: Studies of the mucin-clot prevention test for the determination of the anti- hyaluronidase titre of human serum. J. clin. Invest. 27, 463–470 (1948).Google Scholar
  379. Pribram, A: Antihyaluronidase studies of sera from patients with rheumatic fever, streptococcal infections and miscellaneous non-streptococcal diseases. J. clin. Invest. 27, 471–475 (1948).Google Scholar
  380. Pribram, A: The antihyaluronidase content of human blood serum. A study in age differences. J. Immunol. 61, 185–191 (1949).Google Scholar
  381. Pribram, A: The antitoxin response of Schick negative rheumatic and non-rheumatic subjects to diphtheria toxoid. J. Immunol. 76, 246–252 (1956).Google Scholar
  382. Pribram, A: The response of rheumatic and non-rheumatic children to streptolysin 0 concentrate. J. clin. Invest. 36, 793–802 (1957).Google Scholar
  383. Pribram, A., R. Cerroni: Antigenicity of chondroitin sulfate. Proc. Soc. exp. Biol. (N. Y.) 96, 268–269 (1957).Google Scholar
  384. Pribram, A., S. J. Liao: A comparative study of antihyaluronidase, antistreptolysin “0”, anti- streptokinase, and streptococcal agglutination titers in patients with rheumatic fever, acute hemolytic streptococcal infections, rheumatoid arthritis and non-rheumatoid forms of arthritis. J. clin. Invest. 29, 1156–1166 (1950).Google Scholar
  385. Pribram, A., C.V. Seastone and H.A.Dickie: Antibody production and tuberculin sensitivity in individuals with a history of rheumatic fever. J. Immunol. 70, 493–495 (1953).Google Scholar
  386. Raffel, S: Immunity, Hypersensitivity, Serology. New York: Appleton-Century-Crofts, Inc. 1953.Google Scholar
  387. Raffel, S: Delayed hypersensitivities. Progr. Allergy 4, 173–198; Basel-New York: S. Karger 1954.Google Scholar
  388. Raffel, S: Bacterial hypersensitivity. J. Allergy 27, 199–212 (1956).PubMedGoogle Scholar
  389. Raffel, S: Immunopathology of tuberculosis. Amer. Rev. Tuberc. 74, 60–74 (1956).Google Scholar
  390. Ragan, C., and K. Meyer: The hyaluronic acid of synovial fluid in rheumatoid arthritis. J. clin. Invest. 28, 56–59 (1949).Google Scholar
  391. Rake, G. W: Role of infection in the aetiology of Bright’s disease. Guy’s Hosp. Gaz. 42, 242 und 363 (1928).Google Scholar
  392. Rammelkamp, Ch. H: [1] Glomerulonephritis. Proc. Inst. Med. Chicago 19, 371–384 (1953).PubMedGoogle Scholar
  393. Rammelkamp, Ch. H: [2] Acute hemorrhagic glomerulonephritis. In Streptococcal infections. Edited by M. McCarty. S. 197–207. New York: Columbia University Press 1954.Google Scholar
  394. Rammelkamp, Ch. H: [3] Present status of streptococcal infections in relation to rheumatic fever and glomerulonephritis. Amer. J. clin. Path. 26, 555–558 (1956).Google Scholar
  395. Rammelkamp, Ch. H: [4] Epidemiology of streptococcal infections. Harvey Lect. (1955–1956) Ser. 51, 113–142 (1957).Google Scholar
  396. Rammelkamp, Ch. H: [5] Microbiologic aspects of glomerulonephritis. J. chron. Dis. 5, 28–33 (1957).PubMedGoogle Scholar
  397. Rammelkamp, Ch. H: [6] The Lewis A. Conner memorial lecture. Rheumatic heart disease–a challenge. Circulation 17, 842–851 (1958).PubMedGoogle Scholar
  398. Rammelkamp, Ch. H: [7] Persönliche Mitteilung.Google Scholar
  399. Rammelkamp, Ch. H., F. W. Denny and L. W. Wannamaker: Studies on the epidemiology of rheumatic fever in the armed services. In Rheumatic fever. Edited by L.Thomas. S. 72–89. Minneapolis: University of Minnesota Press 1952.Google Scholar
  400. Rammelkamp, Ch. H., H. B. Hotjser, E. 0. Hahn, L. W. Wannamaker, F. W. Denny and G. E. Eckhardt: The prevention of rheumatic fever. In Rheumatic fever. Edited by L. Thomas. S. 304 bis 315. Minneapolis: University of Minnesota Press 1952.Google Scholar
  401. Rammelkamp, Ch. H., L. W. Wannamaker and F. W. Denny: The epidemiologv and prevention of rheumatic fever. Bull. N. Y. Acad. Med. 28, 321–334 (1952).PubMedGoogle Scholar
  402. Rammelkamp, Ch. H., R. S. Weaver: Acute glomerulonephritis. The significance of the variations in the incidence of the disease. J. clin. Invest. 32, 345–358 (1953).PubMedGoogle Scholar
  403. Rammelkamp, Ch. H., J. H. Dingle: Significance of the epidemiological differences between acuteGoogle Scholar
  404. nephritis and acute rheumatic fever. Trans. Ass. Amer. Physicians 65, 168–175 (1952).Google Scholar
  405. Ramsdell, S. G: Use of trypan blue to demonstrate immediate skin reaction in rabbits and guinea pigs. J. Immunol. 15, 305–311 (1928).Google Scholar
  406. Rantz, L. A: Hemolytic streptococci; studies on carrier state in San Francisco area, with notes on methods of isolation and serological classification of these organisms. J. infect. Dis. 69, 248–253 (1941).Google Scholar
  407. Rantz, L. A: Hemolytic streptococcus otitis media. Stanford Med. Bull. 10, 32–38 (1952).Google Scholar
  408. Rantz, L. A., P. J. Boisvert and W. W. Spink: Hemolytic streptococcus sore throat. The poststrepto- coccic state. Arch, intern. Med. 79, 401–435 (1947).Google Scholar
  409. Rantz, L. A., C. S. Keefer: The distribution of hemolytic streptococci groups A, B and C in human infections. J. infect. Dis. 68, 128–132 (1941).Google Scholar
  410. Rantz, L. A., M. Maroney and J. M. Dicaprio: Antistreptolysin 0 response following hemolytic streptococcus infection in early childhood. Arch, intern. Med. 87, 360–371 (1951).Google Scholar
  411. Rantz, L. A: Infection and reinfection by hemolytic streptococci in early childhood. In RheumaticGoogle Scholar
  412. fever. Edited by L.Thomas. S. 90–103. Minneapolis: University of Minnesota Press 1952.Google Scholar
  413. Rantz, L. A., E. Randall: A modification of the technique for the determination of the antistreptolysin titer. Proc. Soc. exp. Biol. (N. Y.) 59, 22–25 (1945).Google Scholar
  414. Rantz, L. A: Antibacterial precipitating antibodies in group A hemolytic streptococcus sore throat.Google Scholar
  415. Amer. J. Med. 2, 551–567 (1947).Google Scholar
  416. Rantz, L. A., H. H. Rantz: Antistreptolysin “0”; study of this antibody in health and in hemolytic streptococcus respiratory disease in man. Amer. J. Med. 5, 3–23 (1948).PubMedGoogle Scholar
  417. Rantz, L. A: Immunization of human beings with group A hemolytic streptococci. Amer. J. Med.Google Scholar
  418. Ratschow, M: Grundsätzliches zum Problem der Sensibilisierung. Med.Klin. 1953, 1249–1253.Google Scholar
  419. Rauch, S: Isolierung und Charakterisierung des aktiven Prinzips beim tonsillogenen Herdinfekt. Z. Laryng. 28, 415–440 (1949).Google Scholar
  420. Reed, R. W: An epidemic of acute nephritis. Canad. med. Ass. J. 68, 448–455 (1953).Google Scholar
  421. Reubi, F., et H. Löffler: La signification du streptocoque hémolytique du groupe A, type 12, pour le développement de la glomerulonéphrite aiguë. Schweiz, med. Wschr. 1954, 1239 bis 1243.Google Scholar
  422. Rheumatic Fever Working Party of the Medical Research Council of Great Britain and the Subcommittee of Principal Investigators of the American Council on Rheumatic Fever and Congenital Heart Disease, American Heart Association: The treatment of acute rheumatic fever in children. A cooperative clinical trial of ACTH, cortisone and aspirin. Circulation 11, 343–377 (1955).Google Scholar
  423. Rich, A. R: The pathogenesis of tuberculosis. 2nd ed. Springfield, Illinois: Charles C. Thomas 1951.Google Scholar
  424. Rinehart, J. F: Rheumatic fever: Observations on the histogenesis, pathogenesis, and use of ascorbic acid and bioflavonoids. Ann. N. Y. Acad. Sci. 61, 684–699 (1955).PubMedGoogle Scholar
  425. Roemer, G. B: Untersuchungen über den Nachweis von Streptokokkenantikörpern mit Hilfe der indirekten Hämagglutination. Z. Hyg. 143, 445–459 (1957).Google Scholar
  426. Roemer, G. B., L. Grün: Präzipitine im Patientenserum bei Streptokokken-Infektionen. Zbl. Bakt., I. Abt. Orig. 154, 206–210 (1949).Google Scholar
  427. Rogers, H. J: The conditions controlling the production of hyaluronidase by microorganisms grown in simplified media. Biochem. J. 39, 435–443 (1945).Google Scholar
  428. Ropes, M. W., G. A. Bennet, S. Cobb, R. Jacox and R. A. Jessar: Proposed diagnostic criteria for rheumatoid arthritis. Ann. Rheumat. Dis. 16, 118–123 (1957).PubMedGoogle Scholar
  429. Rosebtjry, Th: Focal infection. In Bacterial and mycotic infections of man. Edited by R. J. Dubos, 2nd ed. S. 699–700. Philadelphia: J. B. Lippincott Company 1952.Google Scholar
  430. Rosenow, E. C: The etiology of acute rheumatism, articular and muscular. J. infect. Dis. 14, 61–80 (1914).Google Scholar
  431. Rosenow, E. C: Elective localization of streptococci. J. Amer. med. Ass. 65, 1687–1691 (1915).Google Scholar
  432. Rosenow, E. C: Herdinfektion und elektive Lokalisation. Verh. dtsch. Ges. inn. Med. 42, 408–438 (1930).Google Scholar
  433. Rosenow, E. C: Elective localization and cataphoretic velocity of streptococci isolated from pulpless teeth and other foci of infection; summary of results. J. N. Y. Acad. Dent. 2, 92–98 (1935).Google Scholar
  434. Ross, F: The Arthus phenomenon: Report of a case. J. Amer. med. Ass. 103, 563. (1934).Google Scholar
  435. Rothbard, S: Bacteriostatic effect of human sera on group A streptococci, I: Type-specific antibodies in sera of patients convalescing from group A streptococcal pharyngitis. J. exp. Med. 82, 93–106 (1945).PubMedGoogle Scholar
  436. Rothbard, S: Protective effect of hyaluronidase and type-specific anti-M serum on experimental group A streptococcus infections in mice. J. exp. Med. 88, 325–342 (1948).PubMedGoogle Scholar
  437. Rothbard, S., R. F. Watson: Variation occurring in group A streptococci during human infection. J. exp. Med. 87, 521–533 (1948).PubMedGoogle Scholar
  438. Rothbard, S., H. F. Swift and A. T. Wilson: Bacteriologic and immunologic studies on patients with hemolytic streptococcal infections as related to rheumatic fever. Arch, intern. Med. 82, 229–250 (1948).Google Scholar
  439. Rössle, R: Uber hämorrhagische Reaktionen beim Typhus nach Schutzimpfungen. Dtsch. med. Wschr. 1946, 48–51.Google Scholar
  440. Rudder, B. de: Grundriß einer Meteorobiologie des Menschen. 3. Aufl. Berlin: Springer 1952.Google Scholar
  441. Sachse, H: Über die Agglutinierbarkeit mit Fuller-Extrakt von Streptokokken beladener Erythrozyten durch Kaninchen-Immunserum. Arch. Hyg. 139, 224–233 (1955).Google Scholar
  442. Sachse, H: Untersuchungen über Streptokokken-Hämosensitine. Z. Immun.-Forsch. 113, 333–342 (1956).Google Scholar
  443. Sallman, B., and J. M. Birkeland: The role of hyaluronidase in hemolytic streptococcal infection. Ann. N. Y. Acad. Sci. 52, 1062–1069 (1950).PubMedGoogle Scholar
  444. Sampson, J. J., P. T. Hahman, W. L. Halverson and M. C. Shearer: Incidence of heart disease and rheumatic fever in school children in 3 climatically different California communities. Amer. Heart J. 29, 178–204 (1945).Google Scholar
  445. Sarre, H: Nierenkrankheiten. Stuttgart: Georg Thieme 1958.Google Scholar
  446. Saslaw, M. S., and M. M. Streitfeld: Group A beta hemolytic streptococci in relation to rheumatic fever. Amer. J. Dis. Child. 92, 550–557 (1956).Google Scholar
  447. Sayle, E: The aetiology of rheumatism. Guy’s Hosp. Gaz. 49, 254–260 (1935).Google Scholar
  448. Schaffer, D. E: Further studies into the human serum factor which causes necrosis of guinea-pig skin. Ann. Allergy 15, 487–498 (1957).PubMedGoogle Scholar
  449. Scheiffarth, F: Der gegenwärtige Stand der Allergieforschung. Erg. med. Grundlagenforsch. 1, 443–524. Stuttgart: Georg Thieme 1956.Google Scholar
  450. Sachse, H., G. Berg: Die klinische Bedeutung der Antistreptolysin-Reaktion. Dtsch. med. Wschr. 1957, 1690–1692.Google Scholar
  451. F. Legler u. G. Petersmann: Untersuchungen über die Bedeutung der SerumlipoideGoogle Scholar
  452. für den Antistreptolysintiter. Klin. Wschr. 1957, 412–415.Google Scholar
  453. Sachse, H., A. Bijlitta: Zur Verwertbarkeit verschiedener Methoden der Aktivitätsdiagnostik bei Fokalinfektionen. Z. Laryng. 32, 65–75 (1953).Google Scholar
  454. Sachse, H., F. Legler: Serologische und klinische Erfahrungen mit der Antistreptolysinreaktion bei akutem und chronischem Gelenkrheumatismus. Ärztl. Wschr. 1951, 660–666.Google Scholar
  455. Scherago, M., J. C. Partin and H. E. Hall: A study of the sensitivity of human leukocytes to tuberculin and other bacterial products by the Blatt, Nantz, and Rehm technique. Ann. Allergy 15, 1–13 (1957).PubMedGoogle Scholar
  456. Schlesinger, B: The relationship of throat infection to acute rheumatism in childhood. Arch. Dis. Childh. 5, 411–430 (1930).PubMedGoogle Scholar
  457. Schmidt, H: [1] Beiträge zur Kenntnis der hämolytischen Streptokokken und der Eigenschaften des Antistreptokokkenserums; die Hemmung der Fibrinolyse durch Antistrepto- kokkenserum. Z. Immun. Forsch. 87, 9–16 (1936).Google Scholar
  458. Schmidt, H: [2] Grundlagen der spezifischen Therapie und Prophylaxe bakterieller Infektionskrankheiten. Berlin-Grunewald: Bruno Schultz 1940.Google Scholar
  459. Schmidt, H: [3] Die immunbiologische Bedeutung der Streptokokken für den Rheumatismus. Z. Rheumaforsch. 11, 1–16 (1952).PubMedGoogle Scholar
  460. Schmidt, H: [4] Allergie und Immunität. Dtsch. med. Wschr. 1954, 657–659.Google Scholar
  461. Schmidt, H: [5] Fortschritte der Serologie. 2. Aufl. Darmstadt: Dietrich Steinkopff 1955.Google Scholar
  462. Schmidt, H: [6] Serologische Grundlagen. Experimentelle Serologie. Über Nachweisverfahren von Reaginen in vitro. Die Serumkrankheit. Impfreaktionen. In Allergie, herausgeg. von K. Hansen. S. 44–60, 61–85, 273–278, 342–354, 355–373. Stuttgart: Georg Thieme 1957.Google Scholar
  463. Schmidt, W. C: The cellular localization of injected streptococcal antigens. In Streptococcal infections. Edited by M. McCarty. S. 87–91. New York: Columbia University Press 1954.Google Scholar
  464. Schoen, R: Wege zur Prophylaxe des entzündlichen Rheumatismus. Dtsch. med. Wschr. 1955, 839–844.Google Scholar
  465. Schoen, R., W. Tischendorf: Rheumatische und rheumatoide Krankheiten. In Handbuch der Inneren Medizin, herausgeg. von G. von Bergmann, W. Frey, H. Schwiegk, 4. Aufl. VI/1. S. 907–1042. Berlin: Springer 1954.Google Scholar
  466. Schottmüller, H: Die Artunterscheidung der für den Menschen pathogenen Streptokokken durch Blutagar. Münch, med. Wschr. 1903, 849–853 und 909–912.Google Scholar
  467. Schottmüller, H: Zur Serumtherapie des Scharlachs. Klin. Wschr. 1927, 1692–1696.Google Scholar
  468. Schottmüller, H: Über akute Gelenkentzündungen, ihre Ätiologie und Behandlung. Münch, med. Wschr. 1929, 445–449 u. 449–504.Google Scholar
  469. Schottmüller, H: Diskussionsbemerkung zu: E. C. Rosenow: Herdinfektion und elektive Lokalisation. Verh. dtsch. Ges. inn. Med. 42, 408–438 (1930).Google Scholar
  470. Schultze, H. E., G. Schwick u. H. Vasters: Nachweis von Antistreptolysin 0 mit stabilem Trockenantigen. Untersuchungsergebnisse bei gesunden Personen. Ärztl. Wschr. 1954, 324–328.Google Scholar
  471. Schwentker, F. F., J. H. Janney and J. E. Gordon: The epidemiology of scarlet fever. Amer. J. Hyg. 38, 27–98 (1943).Google Scholar
  472. Seegal, D., and D. P. Earle: A consideration of certain biological differences between glomerulonephritis and rheumatic fever. Amer. J. med. Sci. 201, 528–539 (1941).Google Scholar
  473. Seegal, D., M. Heidelberger, E. L. Jost and J. D. Lyttle: Precipitins against fractions of streptococci in hemolytic streptococcus disease, glomerular nephritis, rheumatoid arthritis and s. viridans endocarditis. Proc. Soc. exp. Biol. (N. Y.) 30, 582–585 (1933).Google Scholar
  474. Seegal, D., B. C. Seegal: Local organ hypersensitiveness. I. Experimental production in the rabbit eye. Proc. Soc. exp. Biol. (N. Y.) 27, 390–393 (1930).Google Scholar
  475. Seegal, D., E. L. Jost: The Arthus phenomenon. Local anaphylactic inflammation in rabbitGoogle Scholar
  476. pericardium, heart and aorta. J. exp. Med. 55, 155–162 (1932).Google Scholar
  477. Seegal, D: A comparative study of the geographic distribution of rheumatic fever, scarletGoogle Scholar
  478. fever, and acute glomerulonephritis in North America. Amer. J. med. Sci. 190, 383–389 (1935).Google Scholar
  479. Seelemann, M: [1] Biologie der Streptokokken. Nürnberg: Hans Carl 1954.Google Scholar
  480. Seelemann, M: [2] Zur Bakteriologie der Herderkrankungen. In Kritische Betrachtung des Herdgeschehens, herausgeg. von K.Thielemann u. E.Thielemann. S. 29–36. München: Carl Hanser 1955.Google Scholar
  481. Seelemann, M., G. Obiger: Biologie, Klassifizierung und Nomenklatur der sog. vergrünenden Streptokokken. Nürnberg: Hans Carl 1958.Google Scholar
  482. Sheldon, W: On acute rheumatism following tonsillitis. Lancet 1931 1, 1337–1341.Google Scholar
  483. Short, C. L., L. Dienes and W. Baijer: Autogenous vaccines in rheumatoid arthritis. A clinical study and critique. Amer. J. med. Sci. 187, 615–623 (1934).Google Scholar
  484. Siegel, A. C., Ch. H. Rammelkamp and H. J. Griffeath: Epidemic nephritis in a school population. The relation of hematuria to group A streptococci. Pediatrics 15, 33–43 (1955).PubMedGoogle Scholar
  485. Siegmund, H: Zur Pathologie der chronischen Streptokokkensepsis. Münch, med. Wschr. 1925, 639–643.Google Scholar
  486. Siegmund, H: Bemerkungen zur allgemein-pathologischen Problematik der Herderkrankungen und einiger Testverfahren. In Diagnose der Herderkrankungen, herausgeg. von Deutsche Arbeitsgemeinschaft für Herdforschung und Herdbekämpfung. S. 11–20. München: Carl Hanser 1953.Google Scholar
  487. Stecher, R. M: Das Problem der Vererbung bei Gelenkerkrankungen. Documenta rheuma- tologica Geigy Nr. 12 (1957).Google Scholar
  488. Stetson, C. A: The pathogenesis of the Shwartzman and Arthus phenomena and their relation to human rheumatic fever. In Rheumatic fever. Edited by L. Thomas. S. 224 bis 231. Minneapolis: University of Minnesota Press 1952.Google Scholar
  489. Stetson, C. A: The relation of antibody response to rheumatic fever. In Streptococcal infections. Edited by M. McCarty. S. 208–218. New York: Columbia University Press 1954.Google Scholar
  490. Stetson, C. A: Studies on the mechanism of the Shwartzman phenomenon. Similarities between reactions to endotoxins and certain reactions of bacterial allergy. J. exp. Med. 101, 421–436 (1955).PubMedGoogle Scholar
  491. Stetson, C. A: The endotoxic properties of lysates of group A hemolytic streptococci. J. exp. Med. 104, 921–934 (1956).PubMedGoogle Scholar
  492. Stetson, C. A., Ch. H. Rammelkamp, R. M. Krause, R. J. Kohen and W. D. Perry: Epidemic acute nephritis: Studies on etiology, natural history and prevention. Medicine 34, 431–450 (1955).PubMedGoogle Scholar
  493. Stevenson, A. C., and E. A. Cheeseman: Heredity and rheumatic fever. Ann. Eugen. 17, 177–210 (1952/53).Google Scholar
  494. Stollerman, G. H: The use of antibiotics for the prevention of rheumatic fever. Amer. J. Med. 17, 757–767 (1954).PubMedGoogle Scholar
  495. Stetson, C. A: A scarlatinal “Nachkrankheit” of Schick: rheumatic fever, 50 years later. Int. Arch. Allergy 12, 287–304 (1958).Google Scholar
  496. Stollerman, G. H: W. F. Lynch, M. A. Dolan, D. Young and J. B. Schwedel: Immunologie evidence of group A streptococcal infections in patients undergoing mitral commissurotomy. Circulation 15, 267–273 (1957).Google Scholar
  497. Svartz, N: Serological changes in rheumatoid arthritis. Rheumatism 12, 76–84 (1956).PubMedGoogle Scholar
  498. Svartz, N: Eine fur den chronischen Gelenkrheumatismus charakteristische Substanz im Blut und in der Gelenkfliissigkeit. Bull, schweiz. Akad. med. Wiss. 12, 99–119 (1956).Google Scholar
  499. Swift, H. F: Factors favoring the onset and continuation of rheumatic fever. Amer. Heart J. 6, 625–636 (1931).Google Scholar
  500. Svartz, N: Rheumatic heart disease. Pathogenesis and etiology in their relation to therapy and prophylaxis. Medicine 19, 417–440 (1940).Google Scholar
  501. Svartz, N: The relationship of streptococcal infections to rheumatic fever. Amer. J. Med. 2, 168–189 (1947).Google Scholar
  502. Svartz, N: The etiology of rheumatic fever. Ann. intern. Med. 31, 715–738 (1949).Google Scholar
  503. Svartz, N: The streptococci. In Bacterial and mycotic infections of man. Edited by R. J. Dubos, 2nd ed. S. 265–323. Philadelphia: J. B. Lippincott Company 1952.Google Scholar
  504. Svartz, N., A. E. Cohn: Cardiac diseases, infectious and noninfectious, in relation to public health. Trans. Coll. Physicians Philadelphia 6, 197–227 (1938).Google Scholar
  505. Svartz, N., C. L. Derick: Reactions of rabbits to non-hemolytic streptococci. II. Skin reactions in intravenously immunized animals. J. exp. Med. 49, 883–897 (1929).Google Scholar
  506. Svartz, N., C. H. Hitchcock: Rheumatic fever as a manifestation of hypersensitiveness (allergy or hyperergy) to streptococci. Trans. Ass. Amer. Physicians 43, 192–202 (1928).Google Scholar
  507. Svartz, N., C. H. Hitchcock and C. L. Derick: General tuberculin-like reactions in rheumatic fever patients following intravenous injection of streptococcus vaccines or nucleoproteins. Proc. Soc. exp. Biol. (N. Y.) 25, 312–313 (1928).Google Scholar
  508. Svartz, N., R. C. Lancefield and K. Goodner: The serological classification of hemolytic streptococci in relation to epidemiological problems. Amer. J. med. Sci. 190, 445–453 (1935).Google Scholar
  509. Svartz, N., M. G. Wilson and E. W. Todd: Skin reactions of patients with rheumatic fever to toxic filtrates of streptococcus. Amer. J. Dis. Child. 37, 98–111 (1929).Google Scholar
  510. Taranta, A., and G. H. Stollerman: The relationship of Sydenham’s chorea to infection with group A streptococci. Amer. J. Med. 20, 170–175 (1956).PubMedGoogle Scholar
  511. Thomas, A. E: Chronic arthritis after recurrent rheumatic fever. Ann. rheum. Dis. 14, 259–266 (1955).PubMedGoogle Scholar
  512. Thomas, L: The generalized Shwartzman reaction in rabbits infected with group A hemolytics streptococci. In Rheumatic fever. Edited by L. Thomas. S. 232–246. Minneapolis: University of Minnesota Press 1952.Google Scholar
  513. Thomson, Scott, and J. Innes: Haemolytic streptococci in cardiac lesions of acute rheumatism. Brit. med. J. 1940 I, 733–736.Google Scholar
  514. Tillett, W. S: The fibrinolytic activity of hemolytic streptococci. Bact. Rev. 2, 161–216 (1938).PubMedGoogle Scholar
  515. Svartz, N., L. B. Edwards and R. L. Garner: Fibrinolytic activity of hemolytic streptococci. The development of resistance to fibrinolysis following acute hemolytic streptococcus infections. J. clin. Invest. 13, 47–78 (1934).Google Scholar
  516. Svartz, N., R. L. Garner: The fibrinolytic activity of hemolytic streptococci. J. exp. Med. 58, 485–502 (1933).Google Scholar
  517. Todd, E. W: Antigenic streptococcal haemolysin. J. exp. Med. 55, 267–280 (1932).PubMedGoogle Scholar
  518. Svartz, N: Antihaemolysin titres in haemolytic streptococcal infections and their significance in rheumatic fever. Brit. J. exp. Path. 13, 248–259 (1932).Google Scholar
  519. Svartz, N: A comparative serological study of streptolysins derived from human and from animal infections, with notes on pneumococcal haemolysin, tetanolysin, and staphylococcus toxin. J. Path. Bact. 39, 299–321 (1934).Google Scholar
  520. Svartz, N: The streptolysins of various groups and types of haemolytic streptococci; a serological investigation. J. Hyg. 39, 1–11 (1939).Google Scholar
  521. Svartz, N: A study of the inhibition of streptococcal proteinase by sera of normal and immune animals and of patients infected with group A hemolytic streptococci. J. exp. Med. 85, 591 bis 606 (1947).Google Scholar
  522. Tuft, L., and S. G. Ramsdell: Antibody studies in serum sickness; study of sera secured by serial bleeding from persons treated with immune serum J. Immunol. 17, 539–543 (1929).Google Scholar
  523. Tunevall, G: Studies on haemophilus influenzae; a complement fixation test for haemo- philus influenzae antibody. Acta path, microbiol. scand. 32, 258–274 (1953).Google Scholar
  524. Svartz, N: The antipneumolysin reaction and its clinical application. Scand. J. clin. Lab. Invest. 5, 109–117 (1953).Google Scholar
  525. Tzanck, A., H. P. Klotz et A. Negreanu: A propos d’un cas de néphrite déclanché par l’anatoxine antistaphylococcique. Bull. Soc. méd. Hôp. Paris 52, 452–455 (1936).Google Scholar
  526. Ungar, G: Biochemical mechanism of the allergic reaction. Inter. Arch. Allergy 4, 258–281 (1953).Google Scholar
  527. Updyke, E. L., M. S. Moore and E. Conroy: Provisional new type of group A streptococci associated with nephritis. Science 121, 171–172 (1955).PubMedGoogle Scholar
  528. Vaxjbel, E: Die Eiweißüberempfindlichkeit (Gewebshyperergie) des Bindegewebes (II. Teil). Experimentelle Untersuchungen zur Erzeugung des rheumatischen Gewebsschadens im Herzen und in den Gelenken. Beitr. path. Anat. 89, 374–418 (1932).Google Scholar
  529. Voit, K: Zur Differentialdiagnose der chronischen Polyarthritis. Münch, med. Wschr. 1958, 447–450.Google Scholar
  530. Voit, K., A. Gamp: Der Rheumatismus. Stuttgart: Ferdinand Enke 1958.Google Scholar
  531. Volhard, F: Die doppelScitigen, hämatogenen Nierenerkrankungen. In Handbuch der Inneren Medizin, herausgeg. von G. von Bergmann und R. Staehelin. 2. Aufl. VI/2, S. 1025–1826. Berlin: Julius Springer 1931.Google Scholar
  532. Voit, K., Th. Fahr: Die Brightsche Nierenkrankheit. Berlin: Julius Springer 1913.Google Scholar
  533. Voss, E. A: Das Prinzip der inversen Anaphylaxie als Methode des Antikörpernachweises beim Menschen. Z. Immun.-Forsch. 94, 281–291 (1938).Google Scholar
  534. Voit, K., Inverse Anaphylaxie beim Menschen, zugleich ein Beitrag zur Problematik der Überempfindlichkeitserscheinungen beim Menschen. Z. Kinderheilk. 59, 612–637 (1938).Google Scholar
  535. Wagner, V., and V. Rejholec: Agglutinins and incomplete antibodies after single antigenic inoculation in normal and rheumatic individuals. Ann. Rheumat. Dis. 14, 243–250 (1955).PubMedGoogle Scholar
  536. Wahrer, C. F: An epidemic of hemorrhagic nephritis following scarlet fever. J. Amer. med. Ass. 51, 1410–1413 (1908).Google Scholar
  537. Waksman, B. H: The etiology of rheumatic fever: A review of theories and evidence. Medicine 28, 143–200 (1949).PubMedGoogle Scholar
  538. Waksman, B. H: Specific white cell lysis produced by combination of rabbit antiserum to purified protein (ovalbumin, bovine gamma globulin) with homologous antigen. The role of non-precipitating antibody. J. Immunol. 70, 331–344 (1953).PubMedGoogle Scholar
  539. Waksman, B. H: Studies of cellular lysis in tuberculin sensitivity. Amer. Rev. Tuberc. 68, 746–759 (1953).Google Scholar
  540. Waksman, B., u. P. Miescher: veröffentlicht bei P. Grabar: Grundbegriffe der Immunologie. In Immunopathologie in Klinik und Forschung, herausgeg. von P. Miescher und K. 0. Vorlaender. S. 56. Stuttgart: Georg Thieme 1957.Google Scholar
  541. Wallace, H. L., and A. B. Smith: The effect of early tonsillectomy on the incidence of acute rheumatism. Edinburgh med. J. 43, 452–457 (1936).Google Scholar
  542. Walthard, K. M., W. Belart, A. Böni, V. Heinemann, D. Högger, V. R. Ott u. F. Wuhr- mann: Vademecum der rheumatischen Krankheiten. Bull. Eidg. Gesundheitsamt B 3/1952, 49.Google Scholar
  543. Wannamaker, L. W: The epidemiology of streptococcal infections. In Streptococcal infections. Edited by M. McCarty. S. 157–175. New York: Columbia University Press 1954.Google Scholar
  544. Waksman, B. H., F. W. Denny, W. D. Perry, Ch. H. Rammelkamp, G. E. Eckhardt, H. B. Houser and E. O. Hahn: The effect of penicillin prophylaxis on streptococcal disease rates and the carrier state. New Engl. J. Med. 249, 1–7 (1953).Google Scholar
  545. Waksman, B. H., F. W. Denny, W. D. Perry, A. C. Siegal and Ch. H. Rammelkamp: Studies on immunity to streptococcal infections in man. Amer. J. Dis. Child. 86, 347–348 (1953).Google Scholar
  546. Waksman, B. H., Ch. H. Rammelkamp, F. W. Denny, W. R. Brink, H. B. Houser, E. O. Hahn and J. H. Dingle: Prophylaxis of acute rheumatic fever by treatment of the preceding streptococcal infection with various amounts of depot penicillin. Amer. J. Med. 10, 673–695 (1951).Google Scholar
  547. Wasielewski, E. von: Weiterer experimenteller Beitrag zur Bedeutung einiger Invasionsstoffe für das Virulenz verhalten von A-Streptokokken. Zbl. Bakt., I. Abt. Orig. 167,585 bis 591 (1956).Google Scholar
  548. Wasson, Y. P: Skin tests in rheumatic fever children. Arch. Pediat. 53, 318–324 (1936).Google Scholar
  549. Watson, D. W: Host factors in experimental streptococcal infections. In Streptococcal infections. Edited by M. McCarty. S. 92–108. New York: Columbia University Press 1954.Google Scholar
  550. Waksman, B. H., R. Dobler: Zit. nach D. W. Watson.Google Scholar
  551. Wedum, B. G., W. Darley and P. H. Rhodes: The incidence of rheumatic heart disease at high altitude. Proc. Centr. Soc. clin. Res. 19, 45–46 (1946).PubMedGoogle Scholar
  552. Weinstein, L., N. H. Boyer and M. Goldfield: Rheumatic heart disease in scarlet-fever patients treated with penicillin. A follow-up study after seven years. New Engl. J. Med. 253, 1–7 (1955).Google Scholar
  553. Weintraud, W: Über die Pathogenese des akuten Gelenkrheumatismus. Berl. klin. Wschr. 1913, 1381–1383.Google Scholar
  554. Weiss, G., L. Florio and G. K. Lewis: Tissue culture studies of cellular hypersensitivity in rheumatic fever. II. The response of fibroblasts from human skin and heart to desintegrated streptococci and to crude filtrates of streptococcal cultures. J. Immunol. 80, 26–31 (1958).PubMedGoogle Scholar
  555. Wertheim, A. It., J. D. Lyttle, E. N. Loeb, D. P. Earle, B. C. Seegal and D. Seegal: The association of type specific hemolytic streptococci with acute glomerulonephritis. J. clin. Invest. 82, 359–363 (1953).Google Scholar
  556. Wesslen, T: Passive transfer of tuberculin hypersensitivity by viable lymphocytes from theGoogle Scholar
  557. thoracic duct. Acta tuberc. scand. 26, 38–53 (1952).Google Scholar
  558. Westergren, A: On a complex etiology in polyarthritis. Acta med. scand. Suppl. 206, 444 bis 453 (1948).Google Scholar
  559. Westergren, A: S. Stavenow: Observations on anti-streptolysin and anti-staphylolysin titers in 855 internal medical cases. Acta med. scand. Suppl. 196, 546–574 (1947).Google Scholar
  560. Westphal, O., P. Lüderitz: Chemische Erforschung von Lipopolysacchariden gramnegativer Bakterien. Angew. Chem. 66, 407–417 (1954).Google Scholar
  561. Wheatley, G. M: Mobilization against rheumatic fever. J. Pediat. 26, 237–244 (1945).Google Scholar
  562. Westphal, O., Some public health aspects of rheumatic fever including the present status of organized efforts to control its effects. W. Virginia med. J. 43, 57–66 (1947).Google Scholar
  563. Wilmers, M. J., A. C. Cunliffe and R. E. O. Williams: Type 12 streptococci associatedGoogle Scholar
  564. with acute haemorrhagic nephritis. Lancet 1954 II, 17–18.Google Scholar
  565. Wilson, G. S., and A. A. Miles: Topley and Wilson’s Principles of Bacteriology and Immunity, 4th ed. London: Edward Arnold 1955.Google Scholar
  566. Wilson, M. G: Rheumatic fever: Studies of the epidemiology, manifestations, diagnosis and treatment of the disease during the first three decades. New York: The Commonwealth Fund 1940.Google Scholar
  567. Wilson, M. G: Hereditary and rheumatic disease. Amer. J. Med. 2, 190–198 (1947).PubMedGoogle Scholar
  568. Wilson, M. G., C. Lingg and G. Croxford: Statistical studies bearing on problems in the classification of heart disease, IV: Tonsillectomy in its relation to the prevention of rheumatic heart disease. Amer. Heart J. 4, 197–209 (1928).Google Scholar
  569. Wilson, M. G., R. Ltjbschez: Longevity in rheumatic fever, based on the experience of 1042 children observed over a period of thirty years. J. Amer. med. Ass. 138, 794–798 (1948).Google Scholar
  570. Wilson, M. G., M. D. Schweitzer: Rheumatic fever as a familial disease. Environment, communi- cability, and heredity in their relation to the observed familial incidence of the disease. J. clin. Invest. 16, 555–570 (1937).PubMedGoogle Scholar
  571. Wilson, M. G:Pattern of hereditary susceptibility in rheumatic fever. Circulation 10, 699–704 (1954).PubMedGoogle Scholar
  572. Winblad, St: Studies in haemolytic streptococcus fibrinolysin, antifibrinolysin and antistreptolysin. Lund: Hakan Ohlsson 1941.Google Scholar
  573. Winblad, St: Studies in haemolytic streptococcus fibrinolysin, antifibrinolysin and antistreptolysin, with particular reference to rheumatic fever. Acta path, microbiol. scand. Suppl. 44, 1 bis 229 (1941).Google Scholar
  574. Winblad, St., H. Malmros and O. Wilander: Studies in the pathogenesis of rheumatic fever. The antistreptolysin titer in acute tonsillitis and rheumatic fever. Acta med. scand. Suppl. 196, 533–544 (1947).Google Scholar
  575. Wood, H. F., and M. McCarty: Laboratory aids in the diagnosis of rheumatic fever and in evaluation of disease activity. Amer. J. Med. 17, 768–774 (1954).PubMedGoogle Scholar
  576. Ziff, M: The agglutination reaction in rheumatoid arthritis. J. chron. Dis. 5, 644–667 (1957).PubMedGoogle Scholar

Copyright information

© Springer-Verlag oHG. Berlin · Göttingen · Heidelberg 1959

Authors and Affiliations

  • P. Christ

There are no affiliations available

Personalised recommendations